Form990-PF

Department of the Treasury
Internal Revenue Service

Return of Private Foundation
or Section 4947(a)(1) Trust Treated as Private Foundation
right arrowDo not enter social security numbers on this form as it may be made public.
right arrowGo to www.irs.gov/Form990PF for instructions and the latest information.
OMB No. 1545-0047
2023
Open to Public Inspection
For calendar year 2023, or tax year beginning 01-01-2023 , and ending 12-31-2023
Name of foundation
JOHN LARSEN FOUNDATION MNG AGY (PLG)
 
Number and street (or P.O. box number if mail is not delivered to street address)PO BOX 0634
 
Room/suite
City or town, state or province, country, and ZIP or foreign postal code
MILWAUKEE, WI532010634
A Employer identification number

41-1715465
B Telephone number (see instructions)

(612) 377-9010
C right arrow
G Check all that apply:

D 1. Foreign organizations, check here............. right arrow
2. Foreign organizations meeting the 85%
test, check here and attach computation ...
right arrow
E right arrow
H Check type of organization:
F right arrow
I Fair market value of all assets at end
of year (from Part II, col. (c),
line 16)right arrow$7,838,154
J Accounting method:
 
(Part I, column (d) must be on cash basis.)
Part I Analysis of Revenue and Expenses (The total of amounts in columns (b), (c), and (d) may not necessarily equal the amounts in column (a) (see instructions).) (a) Revenue and
expenses per
books
(b) Net investment
income
(c) Adjusted net
income
(d) Disbursements
for charitable
purposes
(cash basis only)
Revenue 1 Contributions, gifts, grants, etc., received (attach schedule)  
2 Check right arrow.............
3 Interest on savings and temporary cash investments      
4 Dividends and interest from securities... 145,368 144,982  
5a Gross rents............      
b Net rental income or (loss)  
6a Net gain or (loss) from sale of assets not on line 10 121,215
b Gross sales price for all assets on line 6a 2,058,880
7 Capital gain net income (from Part IV, line 2)... 121,215
8 Net short-term capital gain......... 0
9 Income modifications...........  
10a Gross sales less returns and allowances  
b Less: Cost of goods sold....  
c Gross profit or (loss) (attach schedule).....    
11 Other income (attach schedule)....... 297 297  
12 Total. Add lines 1 through 11........ 266,880 266,494  
Operating and Administrative Expenses 13 Compensation of officers, directors, trustees, etc.        
14 Other employee salaries and wages......   0 0 0
15 Pension plans, employee benefits.......   0 0  
16a Legal fees (attach schedule).........       0
b Accounting fees (attach schedule)....... 1,500 0 0 1,500
c Other professional fees (attach schedule).... 54,689 49,220   5,469
17 Interest...............       0
18 Taxes (attach schedule) (see instructions)... 99 99   0
19 Depreciation (attach schedule) and depletion... 0 0  
20 Occupancy..............        
21 Travel, conferences, and meetings.......   0 0  
22 Printing and publications..........   0 0  
23 Other expenses (attach schedule)....... 2,031 6   2,025
24 Total operating and administrative expenses.
Add lines 13 through 23.......... 58,319 49,325 0 8,994
25 Contributions, gifts, grants paid....... 379,000 379,000
26 Total expenses and disbursements. Add lines 24 and 25 437,319 49,325 0 387,994
27 Subtract line 26 from line 12:
a Excess of revenue over expenses and disbursements -170,439
b Net investment income (if negative, enter -0-) 217,169
c Adjusted net income (if negative, enter -0-)... 0
For Paperwork Reduction Act Notice, see instructions.
Cat. No. 11289X Form 990-PF (2023)
Form 990-PF (2023)
Page 2
Part II Balance Sheets Attached schedules and amounts in the description column
should be for end-of-year amounts only. (See instructions.)
Beginning of year End of year
(a) Book Value (b) Book Value (c) Fair Market Value
Assets 1 Cash—non-interest-bearing............. 48    
2 Savings and temporary cash investments......... 261,484 320,600 320,600
3 Accounts receivable right arrow  
Less: allowance for doubtful accounts right arrow     0 0
4 Pledges receivable right arrow  
Less: allowance for doubtful accounts right arrow        
5 Grants receivable.................      
6 Receivables due from officers, directors, trustees, and other
disqualified persons (attach schedule) (see instructions).....      
7 Other notes and loans receivable (attach schedule) right arrow  
Less: allowance for doubtful accounts right arrow0      
8 Inventories for sale or use..............      
9 Prepaid expenses and deferred charges..........      
10a Investments—U.S. and state government obligations (attach schedule)      
b Investments—corporate stock (attach schedule)....... 3,434,713 Click to see attachment
List of Attached Documents:
// Content
2,625,587
4,674,771
c Investments—corporate bonds (attach schedule)....... 977,539 Click to see attachment
List of Attached Documents:
// Content
1,567,671
1,573,757
11 Investments—land, buildings, and equipment: basis right arrow  
Less: accumulated depreciation (attach schedule) right arrow        
12 Investments—mortgage loans.............      
13 Investments—other (attach schedule).......... 884,903 Click to see attachment
List of Attached Documents:
// Content
878,462
1,267,490
14 Land, buildings, and equipment: basis right arrow  
Less: accumulated depreciation (attach schedule) right arrow        
15 Other assets (describe right arrow) Click to see attachment
List of Attached Documents:
// Content
835
Click to see attachment
List of Attached Documents:
// Content
1,536
Click to see attachment
List of Attached Documents:
// Content
1,536
16 Total assets (to be completed by all filers—see the
instructions. Also, see page 1, item I) 5,559,522 5,393,856 7,838,154
Liabilities 17 Accounts payable and accrued expenses..........    
18 Grants payable.................    
19 Deferred revenue.................    
20 Loans from officers, directors, trustees, and other disqualified persons    
21 Mortgages and other notes payable (attach schedule)......    
22 Other liabilities (describe right arrow)    
23 Total liabilities (add lines 17 through 22).........   0
Net Assets or Fund Balances Foundations that follow FASB ASC 958, check here right arrow
and complete lines 24, 25, 29 and 30.
24 Net assets without donor restrictions...........    
25 Net assets with donor restrictions............    
Foundations that do not follow FASB ASC 958, check here right arrow
and complete lines 26 through 30.
26 Capital stock, trust principal, or current funds........ 5,559,522 5,393,856
27 Paid-in or capital surplus, or land, bldg., and equipment fund    
28 Retained earnings, accumulated income, endowment, or other funds    
29 Total net assets or fund balances (see instructions)..... 5,559,522 5,393,856
30 Total liabilities and net assets/fund balances (see instructions). 5,559,522 5,393,856
Part III
Analysis of Changes in Net Assets or Fund Balances
1
Total net assets or fund balances at beginning of year—Part II, column (a), line 29 (must agree with end-of-year figure reported on prior year’s return) ...............
1
5,559,522
2
Enter amount from Part I, line 27a .....................
2
-170,439
3
Other increases not included in line 2 (itemize) right arrowClick to see attachment
List of Attached Documents:
// Content
3
6,019
4
Add lines 1, 2, and 3 ..........................
4
5,395,102
5
Decreases not included in line 2 (itemize) right arrowClick to see attachment
List of Attached Documents:
// Content
5
1,246
6
Total net assets or fund balances at end of year (line 4 minus line 5)—Part II, column (b), line 29 .
6
5,393,856
Form 990-PF (2023)
Form 990-PF (2023)
Page 3
Part IV
Capital Gains and Losses for Tax on Investment Income
(a) List and describe the kind(s) of property sold (e.g., real estate,
2-story brick warehouse; or common stock, 200 shs. MLC Co.)
(b)
How acquired
P—Purchase
D—Donation
(c)
Date acquired
(mo., day, yr.)
(d)
Date sold
(mo., day, yr.)
1 a 64. BWX TECHNOLOGIES INC     2023-01-05
b 3. CACI INTERNATIONAL INC CL A   2022-09-12 2023-01-05
c 23. PORTLAND GENERAL ELECTRIC CO   2022-04-06 2023-01-05
d 52. REVANCE THERAPEUTICS INC   2022-10-06 2023-01-09
e 31. REVANCE THERAPEUTICS INC     2023-01-10
39. AZEK CO INC CL A     2023-01-12
55. PORTLAND GENERAL ELECTRIC CO   2022-04-06 2023-01-13
6. SILICON LABORATORIES INC   2020-07-09 2023-01-13
29. COHEN STEERS INC     2023-01-17
1. CONMED CORP   2022-05-11 2023-01-17
8. CONMED CORP   2021-11-04 2023-01-17
8. COHEN STEERS INC   2021-03-11 2023-01-18
7. CONMED CORP     2023-01-18
26. FOCUS FINANCIAL PARTNERS A     2023-01-18
4. MESA LABS INC   2020-07-09 2023-01-18
39. REINSURANCE GROUP AMERICA     2023-01-18
12. REVANCE THERAPEUTICS INC   2022-09-12 2023-01-18
52. HELEN OF TROY LTD     2023-01-18
12. COHEN STEERS INC     2023-01-19
50. CROCS INC   2022-11-15 2023-01-19
3. MESA LABS INC   2020-07-09 2023-01-19
10. POWER INTEGRATIONS INC   2022-11-15 2023-01-19
17. SILICON LABORATORIES INC   2020-07-09 2023-01-19
.556 SUMMIT MATERIALS INC CL A   2021-03-04 2023-01-19
24. ALBEMARLE CORP   2018-08-27 2023-01-20
30. BROWN FORMAN CORP CL B   2020-07-09 2023-01-20
561. CABOT OIL & GAS CORP CL A     2023-01-20
15. HOWARD HUGHES CORP/THE   2022-01-26 2023-01-20
2. HOWARD HUGHES CORP/THE   2021-12-07 2023-01-20
24. KEYSIGHT TECHNOLOGIES INC   2016-12-13 2023-01-20
8. L3HARRIS TECHNOLOGIES INC   2020-07-09 2023-01-20
9. RAYMOND JAMES FINL INC   1911-11-11 2023-01-20
32. REPUBLIC SVCS INC COM   2013-03-12 2023-01-20
22. REVANCE THERAPEUTICS INC     2023-01-20
7. SITIME CORP   2022-05-19 2023-01-20
20. NXP SEMICONDUCTORS NV     2023-01-20
31. BROWN FORMAN CORP CL B   2020-07-09 2023-01-23
10. L3HARRIS TECHNOLOGIES INC   2020-07-09 2023-01-23
44. REVANCE THERAPEUTICS INC     2023-01-24
4. TG THERAPEUTICS INC   2023-01-13 2023-01-24
4. CALIX NETWORKS INC   2022-12-08 2023-01-25
18. CALIX NETWORKS INC   2022-10-26 2023-01-25
258. COMSTOCK RESOURCES INC     2023-01-25
3. SILICON LABORATORIES INC   2020-07-09 2023-01-25
33. BROWN FORMAN CORP CL B   2020-07-09 2023-01-26
26. DEXCOM INC   2020-07-09 2023-01-26
11. L3HARRIS TECHNOLOGIES INC   2020-07-09 2023-01-26
5. EASTERN BANKSHARES INC   2022-10-28 2023-01-27
183. EASTERN BANKSHARES INC     2023-01-27
10. VENTYX BIOSCIENCES INC   2022-12-21 2023-01-27
47. CRYPORT INC   2022-04-05 2023-01-30
6. CRYPORT INC   2020-11-23 2023-01-30
14. MA COM TECH SOLUTIONS HLDNGS INC   2021-04-12 2023-01-30
21. BLUEPRINT MEDICINES CORP   2022-08-25 2023-01-31
163. EASTERN BANKSHARES INC     2023-01-31
39. D R HORTON INC   2013-03-12 2023-02-01
28. BROWN FORMAN CORP CL B   2020-07-09 2023-02-02
10. L3HARRIS TECHNOLOGIES INC   2020-07-09 2023-02-02
188. TG THERAPEUTICS INC     2023-02-02
21. BLACKLINE INC     2023-02-03
1. EARTHSTONE ENERGY INC CL A   2022-03-02 2023-02-03
446. EARTHSTONE ENERGY INC CL A     2023-02-03
50. LIVENT CORP   2022-05-04 2023-02-03
45. MP MATLS CORP   2021-03-18 2023-02-03
77. BROWN FORMAN CORP CL B   2020-07-09 2023-02-06
41. EDWARDS LIFESCIENCES CORP COM   2022-08-05 2023-02-06
10. EDWARDS LIFESCIENCES CORP COM   2020-09-17 2023-02-06
4. NXP SEMICONDUCTORS NV   2020-07-09 2023-02-06
48. ARROWHEAD PHARMACEUTICALS INC     2023-02-07
12. ASBURY AUTOMOTIVE GROUP     2023-02-07
27. BJS WHOLESALE CLUB HOLDINGS INC   2020-09-23 2023-02-07
41. HILTON GRAND VACATIONS   2022-04-21 2023-02-07
48. HILTON GRAND VACATIONS     2023-02-07
9. MESA LABS INC   2020-07-09 2023-02-07
42. OMNICELL INC COM     2023-02-07
171. TG THERAPEUTICS INC     2023-02-07
98. VARONIS SYSTEMS INC     2023-02-07
18. WORKIVA INC     2023-02-07
11. AMN HEALTHCARE SERVICES INC   2023-01-11 2023-02-08
27. ASGN INC     2023-02-08
42. BROWN FORMAN CORP CL B   2020-07-09 2023-02-14
1. GRANITE CONSTR CV 2.750% 11/01/24   1911-11-11 2023-02-15
48. BROWN FORMAN CORP CL B   2020-07-09 2023-02-17
1. MERIT MEDICAL SYSTEMS INC COM   1911-11-11 2023-02-17
6. TRANSMEDICS GROUP INC   2023-01-31 2023-02-23
5. NOVANTA INC     2023-02-24
84. VIKING THERAPEUTICS INC   2022-12-21 2023-02-24
7. AMBARELLA INC   2022-05-17 2023-02-24
11. NOVANTA INC   2022-10-04 2023-02-28
100000. CATERPILLAR FIN MTN 2.625% 3/01/23   2018-05-04 2023-03-01
87. PROGRESSIVE CORP OHIO COM   2013-03-12 2023-03-01
26. AXONICS MODULATION TECHNOLOG   2022-08-12 2023-03-06
4. KARUNA THERAPEUTICS INC     2023-03-06
44. VIKING THERAPEUTICS INC     2023-03-06
84. COLUMBIA BKG SYS INC     2023-03-09
23. INDEPENDENT BK CORP MASS   2020-07-09 2023-03-09
20. NVIDIA CORP   2022-03-23 2023-03-09
21. NVIDIA CORP     2023-03-09
4. SERVICENOW INC   2022-09-13 2023-03-09
130. BROOKLINE BANCORP INC   2020-07-09 2023-03-10
11. EVERCORE INC   2023-02-09 2023-03-10
53. FOCUS FINANCIAL PARTNERS A     2023-03-10
163. FOCUS FINANCIAL PARTNERS A     2023-03-10
20. AXSOME THERAPEUTICS INC     2023-03-13
5. MEDPACE HLDGS INC   2023-01-11 2023-03-13
105. DIAMONDROCK HOSPITALITY CO   2023-02-02 2023-03-15
49. AMYLYX PHARMACEUTICALS INC COM   2022-10-10 2023-03-20
225. DIAMONDROCK HOSPITALITY CO   2023-02-02 2023-03-20
153. GRIFFON CORP     2023-03-20
52. H E EQUIPMENT SERVICES INC     2023-03-20
48. HEALTHEQUITY INC     2023-03-20
140. INDEPENDENCE REALTY TRUST IN     2023-03-20
53. TEREX CORP     2023-03-20
41. VENTYX BIOSCIENCES INC     2023-03-20
21. WINTRUST FINANCIAL CORP   2023-02-07 2023-03-20
26. AKERO THERAPEUTICS INC   2022-12-16 2023-03-22
47. AMERICAN STATES WATER CO     2023-03-23
12. BELLRING DISTR LLC COMMON STOCK   2022-09-14 2023-03-23
33. L3HARRIS TECHNOLOGIES INC   2020-07-09 2023-03-23
19. ROPER INDS INC   2020-07-09 2023-03-23
30. ZOETIS INC   2022-06-27 2023-03-23
41. L3HARRIS TECHNOLOGIES INC   2020-07-09 2023-03-24
14. MICROSOFT CORP   2020-07-09 2023-03-24
12. ROPER INDS INC   2022-08-05 2023-03-24
55. HELMERICH PAYNE INC   2022-11-10 2023-03-27
75. RANGER OIL CORP   2023-02-14 2023-03-27
248. WILLSCOT MOBIL MINI HLDNG CORP COM   2021-09-16 2023-03-27
15. ROPER INDS INC   2020-07-09 2023-03-28
78. SOVOS BRANDS INC COM   2023-03-20 2023-03-28
15. ROPER INDS INC   2020-07-09 2023-03-30
16. ROPER INDS INC   2020-07-09 2023-04-03
6. CINTAS CORP   2020-07-09 2023-04-04
10. MASTERCARD INC   2021-02-02 2023-04-04
16. ROPER INDS INC   2020-07-09 2023-04-04
42. AAON INC   2022-04-22 2023-04-05
42. COMFORT SYS USA INC   2021-03-04 2023-04-05
15. ROPER INDS INC     2023-04-10
4. ROPER INDS INC   2020-07-09 2023-04-10
16. PROMETHEUS BIOSCIENCES INC     2023-04-17
16. AAON INC   2022-04-22 2023-04-18
25. ASGN INC     2023-04-18
49. ALBANY INTL CORP CL A   2020-07-09 2023-04-18
62. ALLETE INC   2023-03-20 2023-04-18
17. ASBURY AUTOMOTIVE GROUP     2023-04-18
18. ATKORE INTERNATIONAL GROUP I   2023-02-08 2023-04-18
24. AXSOME THERAPEUTICS INC   2022-06-29 2023-04-18
2. AXONICS MODULATION TECHNOLOG   2022-08-12 2023-04-18
36. AXONICS MODULATION TECHNOLOG   2022-04-08 2023-04-18
67. AZEK CO INC CL A     2023-04-18
73. BJS WHOLESALE CLUB HOLDINGS INC     2023-04-18
153. BWX TECHNOLOGIES INC     2023-04-18
41. BALCHEM CORP   2020-07-09 2023-04-18
152. BELLRING DISTR LLC COMMON STOCK     2023-04-18
14. BLACKLINE INC   2022-12-15 2023-04-18
7. BLACKLINE INC   2020-07-10 2023-04-18
38.0011 BRIDGEBIO PHARMA INC     2023-04-18
91.9989 BRIDGEBIO PHARMA INC   2023-03-08 2023-04-18
199. BROOKLINE BANCORP INC   2020-07-09 2023-04-18
22. CACI INTERNATIONAL INC CL A     2023-04-18
101. CACTUS INC A     2023-04-18
32. CALIX NETWORKS INC     2023-04-18
189. CATALYST PHARMACEUTICAL PART     2023-04-18
21. CHART INDUSTRIES INC     2023-04-18
14. CHART INDUSTRIES INC   2022-02-28 2023-04-18
28. CHEESECAKE FACTORY INC   2023-02-02 2023-04-18
41. CHESAPEAKE UTILITIES CORP     2023-04-18
44. CLEAN HBRS INC     2023-04-18
8.99918 COHEN STEERS INC   2021-02-25 2023-04-18
29.00082 COHEN STEERS INC   2021-02-25 2023-04-18
91.00007 COLUMBIA BKG SYS INC     2023-04-18
64.99993 COLUMBIA BKG SYS INC     2023-04-18
17. COMFORT SYS USA INC     2023-04-18
28. CONMED CORP     2023-04-18
36. CRYPORT INC     2023-04-18
67. CYTOKINETICS INC     2023-04-18
88. DAY ONE BIOPHARMACEUTICALS INC COM     2023-04-18
168. ELEMENT SOLUTIONS INC   2022-08-26 2023-04-18
27. EVERCORE INC     2023-04-18
90. EXTREME NETWORKS INC COM W/RIGHTS ATTACH   2022-12-08 2023-04-18
16. FOX FACTORY HOLDING CORP   2023-01-27 2023-04-18
9. FOX FACTORY HOLDING CORP   2020-07-09 2023-04-18
34. FRANKLIN ELEC INC   2021-05-04 2023-04-18
137. GREEN PLAINS INC.     2023-04-18
50. H E EQUIPMENT SERVICES INC   2021-04-05 2023-04-18
26. HEALTHEQUITY INC   2022-08-25 2023-04-18
62. HELMERICH PAYNE INC     2023-04-18
103.00329 HILTON GRAND VACATIONS     2023-04-18
18.99671 HILTON GRAND VACATIONS   2022-02-04 2023-04-18
16. HOWARD HUGHES CORP/THE     2023-04-18
60. ICF INTERNATIONAL INC     2023-04-18
144. INDEPENDENCE REALTY TRUST IN     2023-04-18
43.05556 INDEPENDENT BK CORP MASS   2020-07-09 2023-04-18
18.94444 INDEPENDENT BK CORP MASS   2020-07-09 2023-04-18
9. KARUNA THERAPEUTICS INC   2022-04-05 2023-04-18
21. KINSALE CAPITAL GROUP INC     2023-04-18
19. LANTHEUS HOLDINGS INC     2023-04-18
141. LESLIES INC   2023-01-04 2023-04-18
75. LESLIES INC   2021-05-07 2023-04-18
117. LIVENT CORP     2023-04-18
70. MP MATLS CORP     2023-04-18
8.99992 MA COM TECH SOLUTIONS HLDNGS INC   2023-03-29 2023-04-18
10.00008 MA COM TECH SOLUTIONS HLDNGS INC   2023-03-29 2023-04-18
14. MA COM TECH SOLUTIONS HLDNGS INC   2021-04-12 2023-04-18
6. MADRIGAL PHARMACEUTICALS INC     2023-04-18
24. MAXLINEAR INC CLASS A   2020-07-09 2023-04-18
47. MCGRATH RENTCORP     2023-04-18
24. MERITAGE HOMES CORPORATION     2023-04-18
65. NEW JERSEY RESOURCES CORP     2023-04-18
21. NOVANTA INC     2023-04-18
21. CHORD ENERGY CORPORATION     2023-04-18
21. CHORD ENERGY CORPORATION   2021-06-10 2023-04-18
31. OMNICELL INC COM     2023-04-18
133. OPTION CARE HEALTH INC     2023-04-18
41. PIEDMONT LITHIUM INC     2023-04-18
73.99978 PORTLAND GENERAL ELECTRIC CO     2023-04-18
9.00022 PORTLAND GENERAL ELECTRIC CO   2022-04-19 2023-04-18
18. PORTLAND GENERAL ELECTRIC CO   2022-04-06 2023-04-18
24. POWER INTEGRATIONS INC     2023-04-18
11. QUALYS INC   2020-07-09 2023-04-18
15. RBC BEARINGS INC   2022-12-15 2023-04-18
35. REATA PHARMACEUTICALS INC     2023-04-18
72. REPLIMUNE GROUP INC     2023-04-18
20.00079 ROGERS CORP     2023-04-18
5.99921 ROGERS CORP   2023-03-31 2023-04-18
22. SPS COMMERCE INC     2023-04-18
12. SHOCKWAVE MEDICAL INC     2023-04-18
16. SILICON LABORATORIES INC     2023-04-18
100.00257 SIMPLY GOOD FOODS COMPANY     2023-04-18
19.99743 SIMPLY GOOD FOODS COMPANY   2023-02-02 2023-04-18
8. SITIME CORP     2023-04-18
15.99954 SOUTHWEST GAS HOLDINGS INC COM     2023-04-18
91.00046 SOUTHWEST GAS HOLDINGS INC COM     2023-04-18
229. SOVOS BRANDS INC COM     2023-04-18
87.99633 STAG INDUSTRIAL INC     2023-04-18
56.00367 STAG INDUSTRIAL INC   2023-01-06 2023-04-18
72. STRIDE INC     2023-04-18
141. SUMMIT MATERIALS INC CL A     2023-04-18
18.9999 SYNAPTICS INC     2023-04-18
4.0001 SYNAPTICS INC   2022-06-21 2023-04-18
197.00113 TEGNA INC   2022-12-05 2023-04-18
90.99887 TEGNA INC   2022-12-05 2023-04-18
43. TEREX CORP     2023-04-18
47. TERRENO REALTY CORP     2023-04-18
64. TERRENO REALTY CORP     2023-04-18
11. TERRENO REALTY CORP   2021-11-08 2023-04-18
27. TRANSMEDICS GROUP INC     2023-04-18
75. VARONIS SYSTEMS INC     2023-04-18
20. VARONIS SYSTEMS INC   2020-08-07 2023-04-18
25. VENTYX BIOSCIENCES INC     2023-04-18
261. VERONA PHARMA PLC A D R     2023-04-18
117. VIKING THERAPEUTICS INC     2023-04-18
82. VIRIDIAN THERAPEUTICS INC     2023-04-18
19. VISTEON CORP   2020-07-09 2023-04-18
34. WALKER & DUNLOP INC     2023-04-18
3. WALKER & DUNLOP INC   2020-07-09 2023-04-18
27. WERNER ENTERPRISES INC   2023-02-02 2023-04-18
49. WERNER ENTERPRISES INC     2023-04-18
53. WERNER ENTERPRISES INC   2020-10-16 2023-04-18
13. WINTRUST FINANCIAL CORP   2023-02-07 2023-04-18
33.99975 WINTRUST FINANCIAL CORP     2023-04-18
13.00025 WINTRUST FINANCIAL CORP   2021-02-24 2023-04-18
25. WORKIVA INC     2023-04-18
14. AMBARELLA INC     2023-04-18
18. HELEN OF TROY LTD   2022-11-11 2023-04-18
18. HELEN OF TROY LTD   2022-11-11 2023-04-18
28. PROTHENA CORP PLC     2023-04-18
93. SCORPIO TANKERS INC     2023-04-18
12. INTUITIVE SURGICAL INC NEW   2020-07-09 2023-04-20
29. ADOBE SYS INC     2023-04-21
29. ALIGN TECH INC COM   2022-02-07 2023-04-21
124. ALPHABET INC CL C   2020-07-09 2023-04-21
58.00001 AMAZON COM INC COM   2020-07-09 2023-04-21
56.99999 AMAZON COM INC COM   2020-07-09 2023-04-21
21. ATLASSIAN CORPORATION CL A   2022-09-29 2023-04-21
23. ATLASSIAN CORPORATION CL A   2022-09-29 2023-04-21
23. AUTODESK INC     2023-04-21
42. AUTODESK INC     2023-04-21
103. CHEWY INC CLASS A     2023-04-21
37. CHEWY INC CLASS A   2021-04-13 2023-04-21
26. CINTAS CORP   2020-07-09 2023-04-21
26. COSTCO WHSL CORP NEW COM   2020-07-09 2023-04-21
112. COSTAR GRP INC COM     2023-04-21
76. DEXCOM INC   2020-07-09 2023-04-21
128. EDWARDS LIFESCIENCES CORP COM     2023-04-21
26. EXTREME NETWORKS INC COM W/RIGHTS ATTACH     2023-04-21
21.00019 GENERAC HOLDINGS INC     2023-04-21
51.99981 GENERAC HOLDINGS INC     2023-04-21
51. IDEX CORP     2023-04-21
35. INTUIT INC COMMON STOCK   2020-07-09 2023-04-21
60. INTUITIVE SURGICAL INC NEW   2020-07-09 2023-04-21
10. LAUDER ESTEE COS INC CL A   2022-06-27 2023-04-21
12. LAUDER ESTEE COS INC CL A   2022-06-27 2023-04-21
35. LAUDER ESTEE COS INC CL A   2020-07-09 2023-04-21
39. LIVENT CORP     2023-04-21
29. LULULEMON ATHLETICA INC     2023-04-21
39. MASTERCARD INC     2023-04-21
149.00015 MATCH GROUP INC NEW     2023-04-21
28.99985 MATCH GROUP INC NEW   2022-11-21 2023-04-21
59. MICROSOFT CORP   2020-07-09 2023-04-21
52. NVIDIA CORP     2023-04-21
69. PROGRESSIVE CORP OHIO COM     2023-04-21
3. S P GLOBAL INC   2023-02-02 2023-04-21
14.00008 S P GLOBAL INC     2023-04-21
10.99992 S P GLOBAL INC     2023-04-21
14.00002 SBA COMMUNICATIONS CORP   2020-07-09 2023-04-21
19.99998 SBA COMMUNICATIONS CORP   2020-07-09 2023-04-21
39. SERVICENOW INC     2023-04-21
40. SHOPIFY INC A   2023-02-14 2023-04-21
139. SHOPIFY INC A     2023-04-21
29. THERMO ELECTRON CORP COM     2023-04-21
50. VEEVA SYSTEMS INC-CLASS A     2023-04-21
56. VIKING THERAPEUTICS INC   2022-12-19 2023-04-21
69. ZOETIS INC   2020-07-09 2023-04-21
14. NXP SEMICONDUCTORS NV   2023-03-09 2023-04-21
41. NXP SEMICONDUCTORS NV   2020-07-09 2023-04-21
2. SHOCKWAVE MEDICAL INC   2022-11-11 2023-04-24
33. VERONA PHARMA PLC A D R     2023-04-24
22. MAXLINEAR INC CLASS A   2020-07-09 2023-04-26
9. WALKER & DUNLOP INC   2020-07-09 2023-04-26
6. SITIME CORP   2022-06-17 2023-04-27
15. CACTUS INC A   2022-07-28 2023-05-02
18. STAG INDUSTRIAL INC   2023-01-06 2023-05-02
22. WALKER & DUNLOP INC   2020-07-09 2023-05-03
23. ASGN INC     2023-05-04
175. BROOKLINE BANCORP INC   2020-07-09 2023-05-04
13. AMBARELLA INC   2022-05-12 2023-05-04
12. CINTAS CORP   2020-07-09 2023-05-08
18. INTUITIVE SURGICAL INC NEW   2020-07-09 2023-05-08
58. NEW JERSEY RESOURCES CORP     2023-05-08
3. SHOCKWAVE MEDICAL INC   2022-05-17 2023-05-08
14. SCORPIO TANKERS INC   2022-12-05 2023-05-09
258. SYNEOS HEALTH INC   2023-03-01 2023-05-11
306. SYNEOS HEALTH INC     2023-05-11
1. TREEHOUSE FOODS INC   1911-11-11 2023-05-11
12. VIKING THERAPEUTICS INC   2022-12-19 2023-05-11
34. ALPHABET INC CL C   2020-07-09 2023-05-16
82. SHOPIFY INC A     2023-05-16
14. ZOETIS INC   2020-07-09 2023-05-16
12. BALCHEM CORP   2022-05-25 2023-05-18
3. CINTAS CORP   2020-07-09 2023-05-19
120. HEXCEL CORP NEW COM   2022-04-18 2023-05-22
57. WOODWARD INC     2023-05-22
4. CHESAPEAKE UTILITIES CORP   2022-03-09 2023-05-24
9. MERITAGE HOMES CORPORATION   2023-01-25 2023-05-24
196. SOVOS BRANDS INC COM   2023-02-08 2023-05-24
75. DAY ONE BIOPHARMACEUTICALS INC COM     2023-05-25
7. NVIDIA CORP   2022-01-21 2023-05-30
26. OPTION CARE HEALTH INC   2022-10-28 2023-05-30
6. CHESAPEAKE UTILITIES CORP     2023-05-31
9. SERVICENOW INC   2020-12-15 2023-06-01
18. BJS WHOLESALE CLUB HOLDINGS INC   2020-07-09 2023-06-02
9. BJS WHOLESALE CLUB HOLDINGS INC   2020-07-09 2023-06-05
13. BJS WHOLESALE CLUB HOLDINGS INC   2020-07-09 2023-06-06
3. SHOCKWAVE MEDICAL INC   2022-05-17 2023-06-06
20. AUTODESK INC   2020-07-09 2023-06-07
23. BJS WHOLESALE CLUB HOLDINGS INC   2020-07-09 2023-06-07
20. BLACKLINE INC   2020-08-27 2023-06-07
1. SHOCKWAVE MEDICAL INC   2023-05-15 2023-06-07
4. SHOCKWAVE MEDICAL INC   2022-05-17 2023-06-07
22. CHEESECAKE FACTORY INC   2023-02-02 2023-06-08
18. SCORPIO TANKERS INC   2022-12-05 2023-06-08
13. RBC BEARINGS INC     2023-06-09
60. STRIDE INC   2022-09-06 2023-06-15
71. IVERIC BIO INC     2023-06-16
12. MP MATLS CORP   2022-10-20 2023-06-20
52. MP MATLS CORP     2023-06-20
42. MCGRATH RENTCORP     2023-06-23
15. HOWARD HUGHES CORP/THE   2021-12-09 2023-06-28
7. CHESAPEAKE UTILITIES CORP   2022-03-30 2023-06-29
42. CRYPORT INC     2023-06-29
42. SHOPIFY INC A   2020-09-18 2023-06-29
86. SHOPIFY INC A   2020-09-18 2023-06-30
34. AXONICS MODULATION TECHNOLOG     2023-07-03
39. BRIDGEBIO PHARMA INC   2023-02-15 2023-07-03
28. CALIX NETWORKS INC     2023-07-03
2. KARUNA THERAPEUTICS INC   2022-04-12 2023-07-03
29. VIRIDIAN THERAPEUTICS INC     2023-07-03
88. APPLIED DIGITAL CORPORATION   2023-05-30 2023-07-06
48. WERNER ENTERPRISES INC   2020-10-16 2023-07-06
28. BELLRING DISTR LLC COMMON STOCK     2023-07-07
53. SHOPIFY INC A   2020-09-18 2023-07-07
11. SCORPIO TANKERS INC     2023-07-07
91. SHOPIFY INC A     2023-07-10
57. SHOPIFY INC A   2023-03-09 2023-07-11
27. SHOPIFY INC A   2022-06-27 2023-07-11
18. BWX TECHNOLOGIES INC     2023-07-12
9. CLEAN HBRS INC   2022-12-08 2023-07-12
5. CONMED CORP   2020-07-09 2023-07-12
12. HEALTHEQUITY INC     2023-07-12
20. SCHRODINGER INC     2023-07-12
1. GRANITE CONSTR CV 2.750% 11/01/24   1911-11-11 2023-07-13
23.9995 TG THERAPEUTICS INC     2023-07-13
23.0005 TG THERAPEUTICS INC   2023-05-02 2023-07-13
34. SCORPIO TANKERS INC   2023-02-07 2023-07-13
40. GREEN PLAINS INC.   2022-09-02 2023-07-14
16. GREEN PLAINS INC.   2021-02-17 2023-07-14
5. OMNICELL INC COM   2022-07-07 2023-07-14
4. TRANSMEDICS GROUP INC   2023-01-11 2023-07-14
316. ACTIVISION BLIZZARD INC     2023-07-17
77. FORTREA HLDGS INC     2023-07-17
7. HEALTHEQUITY INC   2022-08-25 2023-07-17
1. KARUNA THERAPEUTICS INC   2022-04-12 2023-07-17
25. TG THERAPEUTICS INC     2023-07-17
8. CHESAPEAKE UTILITIES CORP   2022-03-30 2023-07-18
177. LESLIES INC     2023-07-18
48. PORTLAND GENERAL ELECTRIC CO     2023-07-18
11. ATLASSIAN CORPORATION CL A   2022-09-29 2023-07-19
3. CHESAPEAKE UTILITIES CORP   2022-11-03 2023-07-19
2. REATA PHARMACEUTICALS INC   2023-03-06 2023-07-19
3. CHESAPEAKE UTILITIES CORP   2022-11-03 2023-07-20
5. CONMED CORP   2020-07-09 2023-07-21
8. MA COM TECH SOLUTIONS HLDNGS INC   2023-04-28 2023-07-21
5. OMNICELL INC COM   2022-11-15 2023-07-21
7. POWER INTEGRATIONS INC   2022-11-11 2023-07-21
4. SPS COMMERCE INC   2023-06-07 2023-07-21
4. SILICON LABORATORIES INC   2022-03-09 2023-07-21
7. CHESAPEAKE UTILITIES CORP   2022-11-03 2023-07-24
36. PIEDMONT LITHIUM INC     2023-07-24
6. CONMED CORP   2020-07-09 2023-07-25
2. MA COM TECH SOLUTIONS HLDNGS INC   2023-04-28 2023-07-25
5. MA COM TECH SOLUTIONS HLDNGS INC   2021-04-12 2023-07-25
9. CONMED CORP   2020-07-09 2023-07-26
8. MA COM TECH SOLUTIONS HLDNGS INC   2022-06-24 2023-07-26
3. SILICON LABORATORIES INC   2020-07-09 2023-07-26
6. SYNAPTICS INC     2023-07-26
25. BWX TECHNOLOGIES INC     2023-07-27
16. OMNICELL INC COM   2022-11-15 2023-07-27
42. TEREX CORP   2021-07-07 2023-07-27
21. EXTREME NETWORKS INC COM W/RIGHTS ATTACH   2023-05-31 2023-07-28
20. REPLIMUNE GROUP INC   2022-12-09 2023-07-28
4. KARUNA THERAPEUTICS INC   2022-04-12 2023-07-31
12. REATA PHARMACEUTICALS INC     2023-07-31
23. STAG INDUSTRIAL INC   2023-01-06 2023-07-31
3. TERRENO REALTY CORP   2023-06-08 2023-07-31
11. TERRENO REALTY CORP   2021-11-11 2023-07-31
18. REATA PHARMACEUTICALS INC     2023-08-01
7. MA COM TECH SOLUTIONS HLDNGS INC   2022-06-24 2023-08-03
6. WALKER & DUNLOP INC   2023-07-13 2023-08-03
5. LANTHEUS HOLDINGS INC   2022-07-23 2023-08-10
8. FRANKLIN ELEC INC   2021-05-04 2023-08-11
25. GREEN PLAINS INC.   2021-02-17 2023-08-11
66. BLACK KNIGHT INC   2023-05-25 2023-08-14
330. BLACK KNIGHT INC     2023-08-14
11. IDEX CORP   2021-02-08 2023-08-14
4. MASTERCARD INC   2020-07-09 2023-08-14
4. NVIDIA CORP   2022-01-21 2023-08-14
18. VEEVA SYSTEMS INC-CLASS A     2023-08-14
5. CHORD ENERGY CORPORATION   2021-06-10 2023-08-15
1. EVOLENT HEALTH INC A   1911-11-11 2023-08-18
44. GREEN PLAINS INC.   2021-02-17 2023-08-18
4. ICF INTERNATIONAL INC   2022-09-26 2023-08-18
.5 AAON INC   2022-04-22 2023-08-25
67. COLUMBIA BKG SYS INC     2023-08-25
3. ONTO INNOVATION INC   2023-07-31 2023-08-30
3. LANTHEUS HOLDINGS INC   2022-10-07 2023-09-01
1. LANTHEUS HOLDINGS INC   2022-07-23 2023-09-01
22. REPLIMUNE GROUP INC   2022-12-09 2023-09-01
125. TEGNA INC     2023-09-01
40. AZEK CO INC CL A   2021-10-22 2023-09-08
5. CACI INTERNATIONAL INC CL A   2022-09-06 2023-09-08
4. CLEAN HBRS INC   2022-12-08 2023-09-08
35. COLUMBIA BKG SYS INC   2023-05-24 2023-09-08
11. VISTEON CORP     2023-09-08
5. VISTEON CORP   2020-07-09 2023-09-08
22. WINTRUST FINANCIAL CORP     2023-09-08
38. ACELYRIN INC COM     2023-09-13
14. ONTO INNOVATION INC     2023-09-18
13. RAMBUS INC     2023-09-18
29. REPLIMUNE GROUP INC     2023-09-18
4. SUPER MICRO COMPUTER INC     2023-09-18
37. COLUMBIA BKG SYS INC   2023-05-24 2023-09-19
11. COLUMBIA BKG SYS INC   2021-02-26 2023-09-19
15. GUARDANT HEALTH INC   2023-09-01 2023-09-19
2. SILICON LABORATORIES INC   2020-07-09 2023-09-19
3. SYNAPTICS INC   2020-10-02 2023-09-19
13. WINTRUST FINANCIAL CORP   2020-07-09 2023-09-21
92. POINT BIOPHARMA GLOBAL INC     2023-09-22
7. SIMPSON MFG CO INC     2023-09-22
10. SYNAPTICS INC   2020-10-02 2023-09-22
39. VIRIDIAN THERAPEUTICS INC   2022-12-05 2023-09-22
22. DEXCOM INC   2023-08-14 2023-09-25
60. DEXCOM INC   2020-07-09 2023-09-25
44. BRIDGEBIO PHARMA INC     2023-09-26
44. CYMABAY THERAPEUTICS INC   2023-08-01 2023-09-26
22. CYTOKINETICS INC   2023-07-28 2023-09-26
7. CYTOKINETICS INC   2022-07-01 2023-09-26
6. LANTHEUS HOLDINGS INC   2022-10-07 2023-09-26
19. MORPHIC HOLDING INC     2023-09-26
3. NOVANTA INC   2023-06-07 2023-09-26
80. VIKING THERAPEUTICS INC     2023-09-26
10. PROTHENA CORP PLC   2022-12-16 2023-09-26
62. INDEPENDENCE REALTY TRUST IN     2023-09-27
34. VIKING THERAPEUTICS INC   2022-12-19 2023-09-27
56. ALLETE INC   2023-03-20 2023-10-03
102. INDEPENDENCE REALTY TRUST IN   2023-01-06 2023-10-03
5. MOONLAKE IMMUNOTHERAPEUTICS CLASS A   2023-07-17 2023-10-03
10. WALKER & DUNLOP INC     2023-10-03
320. BRANDYWINE REALTY TRUST     2023-10-04
52. H E EQUIPMENT SERVICES INC   2021-04-05 2023-10-05
200000. ROYAL BANK MTN 3.700% 10/05/23   2019-03-06 2023-10-05
26. INDEPENDENT BK CORP MASS     2023-10-11
6. KINSALE CAPITAL GROUP INC   2022-09-27 2023-10-11
7. CONMED CORP   2023-10-11 2023-10-12
129. DEXCOM INC     2023-10-12
22. IDEX CORP   2021-02-08 2023-10-12
13. NVIDIA CORP   2022-01-21 2023-10-12
5. NUVALENT INC COM   2023-10-05 2023-10-12
23. OPTION CARE HEALTH INC     2023-10-12
1. SPS COMMERCE INC   2023-07-31 2023-10-12
36. SI BONE INC     2023-10-12
15. VEEVA SYSTEMS INC-CLASS A   2021-01-08 2023-10-12
24. VENTYX BIOSCIENCES INC   2022-12-19 2023-10-12
22. COLUMBIA BKG SYS INC   2021-02-26 2023-10-18
8. CYTOKINETICS INC   2022-07-01 2023-10-18
4. MADRIGAL PHARMACEUTICALS INC     2023-10-18
5. RAMBUS INC   2023-05-18 2023-10-18
2. ROGERS CORP   2023-04-13 2023-10-18
22. AAON INC     2023-10-19
42. FORESTAR GROUP INC     2023-10-19
3. ROGERS CORP   2023-04-13 2023-10-19
37. AZEK CO INC CL A   2023-07-12 2023-10-20
31. IDEX CORP   2021-02-08 2023-10-20
2. NOVANTA INC   2023-06-07 2023-10-20
1. NOVANTA INC   2022-09-28 2023-10-20
2. ROGERS CORP     2023-10-20
4. WORKIVA INC   2022-09-13 2023-10-20
97. IMMUNOGEN INC COM     2023-10-23
2. SPS COMMERCE INC   2023-07-31 2023-10-25
4. ROGERS CORP   2023-02-02 2023-10-26
2. SPS COMMERCE INC   2023-07-31 2023-10-26
2. ONTO INNOVATION INC   2023-06-08 2023-10-30
10. RAMBUS INC     2023-10-30
5. WORKIVA INC   2023-05-22 2023-10-30
3. NOVANTA INC   2022-09-28 2023-11-01
25.99997 LAUDER ESTEE COS INC CL A     2023-11-02
3.00003 LAUDER ESTEE COS INC CL A   2023-06-01 2023-11-02
8. SERVICENOW INC     2023-11-02
8. THERMO ELECTRON CORP COM   2023-09-25 2023-11-02
10. NXP SEMICONDUCTORS NV   2023-06-22 2023-11-02
10. NXP SEMICONDUCTORS NV   2020-07-09 2023-11-02
73. HILTON GRAND VACATIONS     2023-11-03
5. KINSALE CAPITAL GROUP INC   2022-09-27 2023-11-03
41. PBF ENERGY INC CLASS A     2023-11-03
17. NXP SEMICONDUCTORS NV   2020-07-09 2023-11-03
3. LAUDER ESTEE COS INC CL A   2023-05-11 2023-11-06
32. LAUDER ESTEE COS INC CL A     2023-11-06
10. MOONLAKE IMMUNOTHERAPEUTICS CLASS A     2023-11-06
1629. ATT INC     2023-11-07
190. ABBVIE INC   2020-05-08 2023-11-07
165. CME GROUP INC     2023-11-07
345. WALT DISNEY COMPANY     2023-11-07
488. FIDELITY NATIONAL INFO SERV   2013-03-12 2023-11-07
316. PNC FINL SVCS GROUP INC COM     2023-11-07
363. PACKAGING CORP AMER COM     2023-11-07
606. PHILIP MORRIS INTL     2023-11-07
488. MEDTRONIC PLC     2023-11-07
20. FOX FACTORY HOLDING CORP   2020-07-09 2023-11-13
128. LAUDER ESTEE COS INC CL A   2020-07-09 2023-11-13
2. THERMO ELECTRON CORP COM   2023-09-25 2023-11-13
1. THERMO ELECTRON CORP COM   2020-07-09 2023-11-13
68. LIVENT CORP   2022-12-21 2023-11-14
29. HELMERICH PAYNE INC   2022-10-19 2023-11-16
3. KINSALE CAPITAL GROUP INC   2022-09-27 2023-11-16
6. SPS COMMERCE INC     2023-11-16
1. COGNIZANT TECHNOLOGY SOLUTIONS CL A   1911-11-11 2023-11-17
125. DIAMOND OFFSHORE DRILLING INC     2023-11-17
129. SHOALS TECHNOLOGIES GROUP IN CL A     2023-11-17
5. KINSALE CAPITAL GROUP INC   2022-09-27 2023-11-20
35. BELLRING DISTR LLC COMMON STOCK   2022-09-26 2023-11-21
4. MICROSOFT CORP   2020-07-09 2023-11-22
4. SERVICENOW INC   2020-12-10 2023-11-22
.7 MURAL ONCOLOGY PUB LTD   2023-09-12 2023-11-22
2. MURAL ONCOLOGY PUB LTD     2023-11-22
13. ARCBEST CORP     2023-11-27
32. CREDO TECHNOLOGY GROUP HOLDINGS     2023-11-27
15. CREDO TECHNOLOGY GROUP HOLDINGS     2023-11-29
22. CACTUS INC A   2022-07-28 2023-12-06
6. CHORD ENERGY CORPORATION   2021-06-10 2023-12-06
116. PERMIAN RESOURCES CORP CLASS A     2023-12-06
8. CYTOKINETICS INC   2021-07-20 2023-12-11
3. CYTOKINETICS INC   2022-07-01 2023-12-11
10. APPLIED MATLS INC COM   2019-02-26 2023-12-12
20. PROGRESSIVE CORP OHIO COM   2013-03-12 2023-12-12
3. SYNOPSYS INC COM   2013-03-12 2023-12-12
85. IMMUNOGEN INC COM     2023-12-13
14. BWX TECHNOLOGIES INC   2022-09-15 2023-12-15
15. CYTOKINETICS INC   2021-07-20 2023-12-15
14. HEALTHEQUITY INC     2023-12-15
13. ICF INTERNATIONAL INC   2022-09-26 2023-12-15
4. CLEAN HBRS INC   2022-12-08 2023-12-18
20. HEALTHEQUITY INC     2023-12-18
11. LANTHEUS HOLDINGS INC   2022-10-07 2023-12-18
14. PROTHENA CORP PLC   2022-12-16 2023-12-18
14. BWX TECHNOLOGIES INC   2022-09-15 2023-12-20
4. CACI INTERNATIONAL INC CL A   2022-09-06 2023-12-20
5. CLEAN HBRS INC   2022-12-08 2023-12-20
4. CLEAN HBRS INC   2022-12-08 2023-12-20
41. CRINETICS PHARMACEUTICALS IN     2023-12-20
12. CYMABAY THERAPEUTICS INC     2023-12-20
12. CYMABAY THERAPEUTICS INC   2023-07-05 2023-12-20
13. CYTOKINETICS INC   2021-07-20 2023-12-20
10. HEALTHEQUITY INC     2023-12-20
3. HEALTHEQUITY INC   2022-08-25 2023-12-20
13. VAXCYTE INC COM     2023-12-20
8. VAXCYTE INC COM   2023-07-05 2023-12-20
90. IMMATICS N V     2023-12-20
12. HEALTHEQUITY INC   2022-08-25 2023-12-21
11. ROCKET PHARMACEUTICALS INC   2023-09-13 2023-12-21
6. COHEN STEERS INC     2023-12-22
14. E L F BEAUTY INC     2023-12-22
8. EVERCORE INC   2022-11-15 2023-12-22
4. WALKER & DUNLOP INC   2023-12-07 2023-12-22
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
CAPITAL GAIN DIVIDENDS P    
(e)
Gross sales price
(f)
Depreciation allowed
(or allowable)
(g)
Cost or other basis
plus expense of sale
(h)
Gain or (loss)
(e) plus (f) minus (g)
a 3,638   3,578 60
b 923   857 66
c 1,103   1,309 -206
d 1,577   1,601 -24
e 897   885 12
887   1,016 -129
2,638   3,129 -491
900   614 286
2,116   1,987 129
96   110 -14
767   1,236 -469
574   533 41
667   1,056 -389
1,127   912 215
764   884 -120
5,566   2,599 2,967
349   342 7
5,455   5,333 122
857   781 76
6,071   4,831 1,240
585   663 -78
823   810 13
2,463   1,738 725
16   16  
5,947   2,326 3,621
1,961   1,901 60
14,301   13,632 669
1,208   1,358 -150
161   190 -29
4,251   893 3,358
1,521   1,290 231
1,027   168 859
3,916   1,005 2,911
694   614 80
767   1,503 -736
3,307   2,726 581
2,074   1,964 110
1,943   1,613 330
1,429   1,190 239
58   55 3
233   293 -60
1,048   1,329 -281
3,145   4,202 -1,057
471   307 164
2,209   2,091 118
2,765   2,885 -120
2,173   1,774 399
80   97 -17
2,924   3,818 -894
412   327 85
1,017   1,566 -549
130   278 -148
917   812 105
977   1,604 -627
2,614   3,368 -754
3,798   922 2,876
1,883   1,774 109
2,107   1,613 494
3,316   2,420 896
1,594   1,829 -235
13   14 -1
5,987   5,900 87
1,295   1,416 -121
1,522   1,680 -158
5,131   4,879 252
3,229   4,326 -1,097
787   830 -43
746   473 273
1,575   2,239 -664
2,802   2,371 431
1,951   1,110 841
1,917   2,139 -222
2,244   2,474 -230
1,584   1,989 -405
2,323   4,696 -2,373
3,166   1,930 1,236
2,662   2,965 -303
1,636   1,326 310
1,049   1,218 -169
2,456   2,181 275
2,734   2,661 73
280     280
3,128   3,041 87
25     25
463   378 85
782   639 143
921   668 253
638   571 67
1,740   1,361 379
100,000   100,000  
12,439   2,162 10,277
1,454   1,876 -422
776   714 62
508   326 182
2,092   3,888 -1,796
1,645   1,393 252
4,808   5,299 -491
5,048   5,542 -494
1,779   1,817 -38
1,453   1,162 291
1,301   1,441 -140
2,716   2,075 641
8,353   5,601 2,752
1,239   1,029 210
876   1,133 -257
852   1,044 -192
1,537   1,673 -136
1,763   2,236 -473
4,600   4,770 -170
2,240   2,001 239
2,752   3,217 -465
2,177   2,692 -515
2,485   2,466 19
1,540   1,328 212
1,574   1,987 -413
986   1,233 -247
3,912   4,194 -282
381   296 85
6,302   5,321 981
8,108   7,511 597
4,807   5,229 -422
7,889   6,611 1,278
3,900   2,997 903
5,157   5,153 4
1,893   2,750 -857
2,867   3,357 -490
10,990   7,935 3,055
6,475   5,930 545
1,298   1,185 113
6,549   5,930 619
7,020   6,325 695
2,726   1,603 1,123
3,642   3,276 366
7,012   6,325 687
3,867   2,364 1,503
5,485   2,897 2,588
6,504   6,174 330
1,734   1,581 153
3,087   1,814 1,273
1,550   901 649
1,969   1,309 660
4,445   2,518 1,927
3,932   3,993 -61
3,536   3,320 216
2,414   2,563 -149
1,719   930 789
114   144 -30
2,053   2,360 -307
1,730   2,497 -767
5,432   2,845 2,587
9,847   8,475 1,372
5,203   3,758 1,445
5,325   3,641 1,684
878   981 -103
439   607 -168
569   584 -15
1,377   1,537 -160
2,033   1,779 254
6,826   6,187 639
4,273   3,846 427
1,567   2,294 -727
3,347   3,174 173
2,686   2,006 680
1,791   2,012 -221
919   1,132 -213
5,234   5,761 -527
6,324   5,660 664
549   575 -26
1,770   1,854 -84
1,943   3,438 -1,495
1,388   2,995 -1,607
2,242   829 1,413
3,090   2,744 346
729   1,634 -905
2,465   2,701 -236
1,108   1,970 -862
3,094   3,273 -179
3,289   3,184 105
1,670   1,831 -161
1,803   1,852 -49
1,014   738 276
3,021   2,935 86
4,600   5,063 -463
2,143   1,918 225
1,511   1,629 -118
2,272   2,829 -557
4,797   4,785 12
885   901 -16
1,242   1,509 -267
6,597   6,571 26
2,305   2,548 -243
2,604   2,607 -3
1,146   1,147 -1
1,802   1,239 563
6,709   5,433 1,276
1,702   1,939 -237
1,531   1,764 -233
814   2,072 -1,258
2,639   2,970 -331
1,829   2,406 -577
565   628 -63
628   698 -70
880   812 68
1,734   1,655 79
750   603 147
4,215   4,624 -409
3,038   2,547 491
3,459   2,896 563
3,276   3,043 233
3,012   3,149 -137
3,012   1,878 1,134
1,786   3,258 -1,472
4,200   4,341 -141
2,363   2,720 -357
3,685   3,872 -187
448   485 -37
896   1,024 -128
1,861   1,959 -98
1,395   1,204 191
3,309   3,270 39
3,435   3,163 272
1,169   1,871 -702
3,190   3,148 42
957   978 -21
3,297   3,397 -100
3,183   3,012 171
2,736   2,791 -55
3,564   3,788 -224
713   731 -18
959   1,522 -563
922   989 -67
5,247   7,016 -1,769
3,959   3,353 606
2,919   3,162 -243
1,857   1,878 -21
2,734   2,850 -116
3,804   3,495 309
1,892   2,544 -652
398   488 -90
3,329   3,955 -626
1,538   1,827 -289
1,986   1,945 41
2,901   3,053 -152
3,951   4,047 -96
679   821 -142
1,900   1,667 233
1,902   2,097 -195
507   787 -280
892   792 100
5,657   4,462 1,195
2,343   1,236 1,107
2,305   2,779 -474
2,886   1,274 1,612
2,306   3,300 -994
204   138 66
1,257   1,335 -78
2,281   2,141 140
2,461   2,280 181
931   1,230 -299
2,434   1,919 515
931   965 -34
2,543   2,049 494
950   1,090 -140
1,561   1,822 -261
1,561   1,822 -261
1,476   1,678 -202
5,691   5,268 423
3,575   2,306 1,269
10,938   13,793 -2,855
10,287   14,447 -4,160
13,148   9,371 3,777
6,259   9,216 -2,957
6,151   9,057 -2,906
3,326   4,418 -1,092
3,643   4,839 -1,196
4,482   4,768 -286
8,185   10,899 -2,714
3,380   4,101 -721
1,214   3,169 -1,955
11,971   6,945 5,026
13,209   8,499 4,710
7,834   7,633 201
9,509   8,432 1,077
11,102   8,947 2,155
408   515 -107
2,174   2,538 -364
5,384   6,262 -878
11,097   10,161 936
15,785   10,769 5,016
17,996   11,532 6,464
2,561   2,640 -79
3,073   3,169 -96
8,963   6,608 2,355
762   841 -79
10,946   9,188 1,758
14,605   11,786 2,819
5,205   6,654 -1,449
1,013   1,360 -347
16,877   12,632 4,245
14,062   13,002 1,060
9,454   9,994 -540
1,058   1,162 -104
4,936   5,575 -639
3,878   4,496 -618
3,594   4,288 -694
5,134   6,125 -991
18,431   22,278 -3,847
1,946   1,961 -15
6,762   15,982 -9,220
16,553   12,803 3,750
9,313   14,946 -5,633
1,171   388 783
12,208   9,471 2,737
2,371   2,578 -207
6,943   4,852 2,091
563   499 64
754   364 390
641   553 88
568   414 154
642   973 -331
572   600 -28
622   604 18
1,449   1,011 438
1,491   1,156 335
1,331   1,565 -234
832   927 -95
5,531   3,205 2,326
5,450   3,459 1,991
2,913   2,525 388
820   493 327
648   747 -99
10,776   10,548 228
12,781   12,984 -203
443     443
272   83 189
4,056   2,569 1,487
5,050   7,548 -2,498
2,543   1,922 621
1,474   1,493 -19
1,413   801 612
8,690   6,777 1,913
6,210   6,800 -590
506   554 -48
1,044   945 99
3,513   2,816 697
903   1,575 -672
2,805   1,694 1,111
711   827 -116
760   831 -71
4,898   4,809 89
1,115   698 417
557   349 208
812   504 308
866   493 373
4,045   4,948 -903
1,457   892 565
1,060   1,701 -641
285   280 5
1,139   657 482
741   889 -148
808   961 -153
2,742   2,793 -51
2,332   2,329 3
2,748   2,428 320
264   312 -48
1,145   1,619 -474
3,821   4,079 -258
1,160   1,402 -242
831   970 -139
723   1,872 -1,149
2,684   3,759 -1,075
5,550   7,696 -2,146
1,720   1,878 -158
686   655 31
1,385   1,864 -479
432   270 162
698   780 -82
677   808 -131
2,084   2,065 19
980   647 333
3,320   4,743 -1,423
499   585 -86
5,583   5,747 -164
3,586   2,521 1,065
1,699   1,006 693
1,274   993 281
1,502   1,065 437
673   348 325
777   783 -6
1,095   821 274
15     15
522   745 -223
500   719 -219
1,510   1,804 -294
1,293   1,441 -148
517   413 104
362   468 -106
369   231 138
29,415   12,007 17,408
2,518   1,301 1,217
431   439 -8
211   135 76
534   876 -342
951   1,109 -158
990   4,452 -3,462
2,210   2,757 -547
2,080   2,314 -234
363   330 33
226   176 50
368   330 38
612   348 264
524   532 -8
315   279 36
647   547 100
724   670 54
632   568 64
849   769 80
1,902   1,801 101
721   418 303
136   133 3
340   290 50
1,100   626 474
541   380 161
437   307 130
535   726 -191
1,702   1,365 337
993   892 101
2,399   1,898 501
571   440 131
404   501 -97
798   539 259
1,987   1,054 933
833   771 62
178   184 -6
651   832 -181
2,993   1,561 1,432
521   332 189
522   538 -16
339   484 -145
764   691 73
823   646 177
4,929   3,663 1,266
24,646   14,725 9,921
2,444   2,125 319
1,593   1,178 415
1,723   968 755
3,461   5,097 -1,636
763   447 316
134     134
1,396   1,137 259
501   429 72
30   19 11
1,323   1,480 -157
409   372 37
202   200 2
67   97 -30
433   551 -118
1,949   2,491 -542
1,305   1,476 -171
1,585   1,377 208
661   473 188
709   732 -23
1,512   1,685 -173
687   335 352
1,659   1,227 432
381   895 -514
1,744   1,634 110
719   817 -98
518   685 -167
970   1,072 -102
748   774 -26
222   519 -297
417   512 -95
234   205 29
252   236 16
973   503 470
642   986 -344
1,027   875 152
826   788 38
602   1,036 -434
1,888   2,530 -642
5,148   6,657 -1,509
1,224   1,518 -294
659   568 91
667   731 -64
212   282 -70
391   399 -8
431   911 -480
421   511 -90
946   1,475 -529
469   587 -118
880   1,094 -214
376   235 141
2,819   3,607 -788
1,380   1,725 -345
286   286  
691   891 -200
1,238   1,599 -361
2,100   1,995 105
200,000   200,000  
1,264   1,566 -302
2,631   1,460 1,171
637   684 -47
9,963   13,820 -3,857
4,565   4,249 316
6,087   3,147 2,940
298   294 4
716   784 -68
168   181 -13
621   994 -373
3,240   4,225 -985
465   759 -294
439   1,038 -599
275   322 -47
543   1,002 -459
290   292 -2
253   327 -74
1,167   811 356
956   981 -25
372   491 -119
954   1,140 -186
6,017   5,988 29
271   341 -70
136   122 14
249   322 -73
395   278 117
1,234   1,705 -471
313   361 -48
476   566 -90
314   361 -47
226   225 1
499   535 -36
463   481 -18
395   366 29
2,979   4,591 -1,612
344   551 -207
4,822   4,273 549
3,570   4,031 -461
1,780   1,945 -165
1,780   1,184 596
2,711   3,370 -659
1,695   1,216 479
1,878   2,227 -349
3,109   2,012 1,097
337   623 -286
3,590   7,274 -3,684
394   570 -176
25,738   35,774 -10,036
26,967   15,875 11,092
35,100   27,052 8,048
29,137   38,917 -9,780
24,861   18,832 6,029
38,242   38,228 14
56,959   23,154 33,805
55,283   55,443 -160
35,358   38,127 -2,769
1,127   1,639 -512
14,452   24,167 -9,715
885   1,008 -123
442   388 54
952   1,424 -472
1,072   1,247 -175
1,056   730 326
1,061   1,077 -16
36     36
1,548   1,988 -440
1,890   2,685 -795
1,772   1,216 556
1,714   773 941
1,511   856 655
2,679   2,136 543
2   9 -7
7   25 -18
1,553   1,507 46
614   518 96
285   240 45
889   880 9
932   537 395
1,451   1,533 -82
283   229 54
106   121 -15
1,570   396 1,174
3,278   497 2,781
1,699   106 1,593
2,525   1,090 1,435
1,082   754 328
541   429 112
883   1,032 -149
1,746   1,396 350
704   473 231
1,270   1,444 -174
619   732 -113
511   822 -311
1,072   754 318
1,266   1,101 165
887   592 295
706   473 233
1,495   1,123 372
268   150 118
266   144 122
476   372 104
641   703 -62
192   188 4
789   644 145
479   393 86
854   847 7
783   752 31
311   232 79
447   383 64
1,965   1,580 385
1,356   932 424
428   369 59
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
      514
Complete only for assets showing gain in column (h) and owned by the foundation on 12/31/69 (l)
Gains (Col. (h) gain minus
col. (k), but not less than -0-) or
Losses (from col.(h))
(i)
F.M.V. as of 12/31/69
(j)
Adjusted basis
as of 12/31/69
(k)
Excess of col. (i)
over col. (j), if any
a       60
b       66
c       -206
d       -24
e       12
      -129
      -491
      286
      129
      -14
      -469
      41
      -389
      215
      -120
      2,967
      7
      122
      76
      1,240
      -78
      13
      725
       
      3,621
      60
      669
      -150
      -29
      3,358
      231
      859
      2,911
      80
      -736
      581
      110
      330
      239
      3
      -60
      -281
      -1,057
      164
      118
      -120
      399
      -17
      -894
      85
      -549
      -148
      105
      -627
      -754
      2,876
      109
      494
      896
      -235
      -1
      87
      -121
      -158
      252
      -1,097
      -43
      273
      -664
      431
      841
      -222
      -230
      -405
      -2,373
      1,236
      -303
      310
      -169
      275
      73
      280
      87
      25
      85
      143
      253
      67
      379
       
      10,277
      -422
      62
      182
      -1,796
      252
      -491
      -494
      -38
      291
      -140
      641
      2,752
      210
      -257
      -192
      -136
      -473
      -170
      239
      -465
      -515
      19
      212
      -413
      -247
      -282
      85
      981
      597
      -422
      1,278
      903
      4
      -857
      -490
      3,055
      545
      113
      619
      695
      1,123
      366
      687
      1,503
      2,588
      330
      153
      1,273
      649
      660
      1,927
      -61
      216
      -149
      789
      -30
      -307
      -767
      2,587
      1,372
      1,445
      1,684
      -103
      -168
      -15
      -160
      254
      639
      427
      -727
      173
      680
      -221
      -213
      -527
      664
      -26
      -84
      -1,495
      -1,607
      1,413
      346
      -905
      -236
      -862
      -179
      105
      -161
      -49
      276
      86
      -463
      225
      -118
      -557
      12
      -16
      -267
      26
      -243
      -3
      -1
      563
      1,276
      -237
      -233
      -1,258
      -331
      -577
      -63
      -70
      68
      79
      147
      -409
      491
      563
      233
      -137
      1,134
      -1,472
      -141
      -357
      -187
      -37
      -128
      -98
      191
      39
      272
      -702
      42
      -21
      -100
      171
      -55
      -224
      -18
      -563
      -67
      -1,769
      606
      -243
      -21
      -116
      309
      -652
      -90
      -626
      -289
      41
      -152
      -96
      -142
      233
      -195
      -280
      100
      1,195
      1,107
      -474
      1,612
      -994
      66
      -78
      140
      181
      -299
      515
      -34
      494
      -140
      -261
      -261
      -202
      423
      1,269
      -2,855
      -4,160
      3,777
      -2,957
      -2,906
      -1,092
      -1,196
      -286
      -2,714
      -721
      -1,955
      5,026
      4,710
      201
      1,077
      2,155
      -107
      -364
      -878
      936
      5,016
      6,464
      -79
      -96
      2,355
      -79
      1,758
      2,819
      -1,449
      -347
      4,245
      1,060
      -540
      -104
      -639
      -618
      -694
      -991
      -3,847
      -15
      -9,220
      3,750
      -5,633
      783
      2,737
      -207
      2,091
      64
      390
      88
      154
      -331
      -28
      18
      438
      335
      -234
      -95
      2,326
      1,991
      388
      327
      -99
      228
      -203
      443
      189
      1,487
      -2,498
      621
      -19
      612
      1,913
      -590
      -48
      99
      697
      -672
      1,111
      -116
      -71
      89
      417
      208
      308
      373
      -903
      565
      -641
      5
      482
      -148
      -153
      -51
      3
      320
      -48
      -474
      -258
      -242
      -139
      -1,149
      -1,075
      -2,146
      -158
      31
      -479
      162
      -82
      -131
      19
      333
      -1,423
      -86
      -164
      1,065
      693
      281
      437
      325
      -6
      274
      15
      -223
      -219
      -294
      -148
      104
      -106
      138
      17,408
      1,217
      -8
      76
      -342
      -158
      -3,462
      -547
      -234
      33
      50
      38
      264
      -8
      36
      100
      54
      64
      80
      101
      303
      3
      50
      474
      161
      130
      -191
      337
      101
      501
      131
      -97
      259
      933
      62
      -6
      -181
      1,432
      189
      -16
      -145
      73
      177
      1,266
      9,921
      319
      415
      755
      -1,636
      316
      134
      259
      72
      11
      -157
      37
      2
      -30
      -118
      -542
      -171
      208
      188
      -23
      -173
      352
      432
      -514
      110
      -98
      -167
      -102
      -26
      -297
      -95
      29
      16
      470
      -344
      152
      38
      -434
      -642
      -1,509
      -294
      91
      -64
      -70
      -8
      -480
      -90
      -529
      -118
      -214
      141
      -788
      -345
       
      -200
      -361
      105
       
      -302
      1,171
      -47
      -3,857
      316
      2,940
      4
      -68
      -13
      -373
      -985
      -294
      -599
      -47
      -459
      -2
      -74
      356
      -25
      -119
      -186
      29
      -70
      14
      -73
      117
      -471
      -48
      -90
      -47
      1
      -36
      -18
      29
      -1,612
      -207
      549
      -461
      -165
      596
      -659
      479
      -349
      1,097
      -286
      -3,684
      -176
      -10,036
      11,092
      8,048
      -9,780
      6,029
      14
      33,805
      -160
      -2,769
      -512
      -9,715
      -123
      54
      -472
      -175
      326
      -16
      36
      -440
      -795
      556
      941
      655
      543
      -7
      -18
      46
      96
      45
      9
      395
      -82
      54
      -15
      1,174
      2,781
      1,593
      1,435
      328
      112
      -149
      350
      231
      -174
      -113
      -311
      318
      165
      295
      233
      372
      118
      122
      104
      -62
      4
      145
      86
      7
      31
      79
      64
      385
      424
      59
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
       
2 Capital gain net income or (net capital loss) Bracket If gain, also enter in Part I, line 7
If (loss), enter -0- in Part I, line 7
Bracket 2 121,215
3 Net short-term capital gain or (loss) as defined in sections 1222(5) and (6):
If gain, also enter in Part I, line 8, column (c) (see instructions). If (loss), enter -0-
in Part I, line 8 ...................
Bracket 3  
Part V
Excise Tax Based on Investment Income (Section 4940(a), 4940(b), 4940(e), or 4948—see instructions)
1a Exempt operating foundations described in section 4940(d)(2), check here right arrow and enter “N/A" on line 1. Bracket for line 1a
Date of ruling or determination letter:   (attach copy of letter if necessary–see instructions) 1 3,019
b All other domestic foundations enter 1.39% (0.0139) of line 27b. Exempt foreign organizations enter 4% (0.04) of Part I, line 12, col. (b)
2 Tax under section 511 (domestic section 4947(a)(1) trusts and taxable foundations only. Others enter -0-) 2 0
3 Add lines 1 and 2........................... 3 3,019
4 Subtitle A (income) tax (domestic section 4947(a)(1) trusts and taxable foundations only. Others enter -0-) 4 0
5 Tax based on investment income. Subtract line 4 from line 3. If zero or less, enter -0- ..... 5 3,019
6 Credits/Payments:
a 2023 estimated tax payments and 2022 overpayment credited to 2023 6a 2,516
b Exempt foreign organizations—tax withheld at source...... 6b 0
c Tax paid with application for extension of time to file (Form 8868)... 6c 0
d Backup withholding erroneously withheld .......... 6d  
7 Total credits and payments. Add lines 6a through 6d.............. 7 2,516
8 Enter any penalty for underpayment of estimated tax. Check here if Form 2220 is attached. 8 0
9 Tax due. If the total of lines 5 and 8 is more than line 7, enter amount owed.......right arrow 9 503
10 Overpayment. If line 7 is more than the total of lines 5 and 8, enter the amount overpaid...right arrow 10  
11 Enter the amount of line 10 to be: Credited to 2024 estimated taxright arrow0 Refundedright arrow 11 0
Form 990-PF (2023)
Form 990-PF (2023)
Page 4
Part VI-A
Statements Regarding Activities
1a
During the tax year, did the foundation attempt to influence any national, state, or local legislation or did
Yes
No
it participate or intervene in any political campaign? ....................
1a
 
No
b
Did it spend more than $100 during the year (either directly or indirectly) for political purposes? See the instructions
for the definition.................................
1b
 
No
If the answer is "Yes" to 1a or 1b, attach a detailed description of the activities and copies of any materials
published or distributed by the foundation in connection with the activities.
c
Did the foundation file Form 1120-POL for this year?.....................
1c
 
No
d
Enter the amount (if any) of tax on political expenditures (section 4955) imposed during the year:
(1) On the foundation. right arrow$   (2) On foundation managers.right arrow$  
e
Enter the reimbursement (if any) paid by the foundation during the year for political expenditure tax imposed
on foundation managers.right arrow$  
2
Has the foundation engaged in any activities that have not previously been reported to the IRS?.......
2
 
No
If "Yes," attach a detailed description of the activities.
3
Has the foundation made any changes, not previously reported to the IRS, in its governing instrument, articles
of incorporation, or bylaws, or other similar instruments? If "Yes," attach a conformed copy of the changes....
3
 
No
4a
Did the foundation have unrelated business gross income of $1,000 or more during the year?.........
4a
 
No
b
If "Yes," has it filed a tax return on Form 990-T for this year?...................
4b
 
 
5
Was there a liquidation, termination, dissolution, or substantial contraction during the year?.........
5
 
No
If "Yes," attach the statement required by General Instruction T.
6
Are the requirements of section 508(e) (relating to sections 4941 through 4945) satisfied either:
round bullet By language in the governing instrument, or
round bullet By state legislation that effectively amends the governing instrument so that no mandatory directions
that conflict with the state law remain in the governing instrument? ................
6
Yes
 
7
Did the foundation have at least $5,000 in assets at any time during the year? If "Yes," complete Part II, col. (c),
and Part XIV..................................
7
Yes
 
8a
Enter the states to which the foundation reports or with which it is registered (see instructions)
right arrowMN
b
If the answer is "Yes" to line 7, has the foundation furnished a copy of Form 990-PF to the Attorney
General (or designate) of each state as required by General Instruction G? If "No," attach explanation .
8b
Yes
 
9
Is the foundation claiming status as a private operating foundation within the meaning of section 4942(j)(3)
or 4942(j)(5) for calendar year 2023 or the taxable year beginning in 2023? See the instructions for Part XIII.
If "Yes," complete Part XIII .............................
9
 
No
10
Did any persons become substantial contributors during the tax year? If "Yes," attach a schedule listing their names
and addresses. ...............................
10
 
No
11
At any time during the year, did the foundation, directly or indirectly, own a controlled entity within the
meaning of section 512(b)(13)? If "Yes," attach schedule. See instructions .............
11
 
No
12
Did the foundation make a distribution to a donor advised fund over which the foundation or a disqualified person had
advisory privileges? If "Yes," attach statement. See instructions.................
12
 
No
13
Did the foundation comply with the public inspection requirements for its annual returns and exemption application?
13
Yes
 
Website addressright arrowJOHNLARSENFOUNDATION.ORG
14
The books are in care ofright arrowJOHN E LARSEN, C/O US BANK NATL ASS Telephone no.right arrow (855) 452-4091

Located atright arrow101 E 5TH STREETST PAULMN ZIP+4right arrow551640713
15
Section 4947(a)(1) nonexempt charitable trusts filing Form 990-PF in lieu of Form 1041 —check here .........right arrow
and enter the amount of tax-exempt interest received or accrued during the year ........right arrow
15
 
16 At any time during calendar year 2023, did the foundation have an interest in or a signature or other authority over YesNo
a bank, securities, or other financial account in a foreign country? .................
16   No
See the instructions for exceptions and filing requirements for FinCEN Form 114. If "Yes", enter the name of the foreign
country right arrow
Form 990-PF (2023)
Form 990-PF (2023)
Page 5
Part VI-B
Statements Regarding Activities for Which Form 4720 May Be Required
File Form 4720 if any item is checked in the "Yes" column, unless an exception applies.
Yes
No
1a
During the year did the foundation (either directly or indirectly):
(1) Engage in the sale or exchange, or leasing of property with a disqualified person? ...........
1a(1)
 
No
(2) Borrow money from, lend money to, or otherwise extend credit to (or accept it from)
a disqualified person? ..............................
1a(2)
 
No
(3) Furnish goods, services, or facilities to (or accept them from) a disqualified person? ...........
1a(3)
 
No
(4) Pay compensation to, or pay or reimburse the expenses of, a disqualified person? ............
1a(4)
 
No
(5) Transfer any income or assets to a disqualified person (or make any of either available
for the benefit or use of a disqualified person)? ......................
1a(5)
 
No
(6) Agree to pay money or property to a government official? (Exception. Check "No"
if the foundation agreed to make a grant to or to employ the official for a period
after termination of government service, if terminating within 90 days.) ...............
1a(6)
 
No
b
If any answer is "Yes" to 1a(1)–(6), did any of the acts fail to qualify under the exceptions described in Regulations
section 53.4941(d)-3 or in a current notice regarding disaster assistance? See instructions ..........
1b
 
 
c
Organizations relying on a current notice regarding disaster assistance check here ........right arrow
d
Did the foundation engage in a prior year in any of the acts described in 1a, other than excepted acts,
that were not corrected before the first day of the tax year beginning in 2023? .............
1d
 
No
2
Taxes on failure to distribute income (section 4942) (does not apply for years the foundation was a private
operating foundation defined in section 4942(j)(3) or 4942(j)(5)):
a
At the end of tax year 2023, did the foundation have any undistributed income (Part XII, lines 6d
and 6e) for tax year(s) beginning before 2023?....................
2a
 
No
If "Yes," list the years right arrow20, 20, 20, 20
b
Are there any years listed in 2a for which the foundation is not applying the provisions of section 4942(a)(2)
(relating to incorrect valuation of assets) to the year’s undistributed income? (If applying section 4942(a)(2)
to all years listed, answer "No" and attach statement—see instructions.) ..............
2b
 
 
c
If the provisions of section 4942(a)(2) are being applied to any of the years listed in 2a, list the years here.
right arrow20, 20, 20, 20
3a
Did the foundation hold more than a 2% direct or indirect interest in any business enterprise at
any time during the year? ..............................
3a
 
No
b
If "Yes," did it have excess business holdings in 2023 as a result of (1) any purchase by the foundation
or disqualified persons after May 26, 1969; (2) the lapse of the 5-year period (or longer period approved
by the Commissioner under section 4943(c)(7)) to dispose of holdings acquired by gift or bequest; or (3)
the lapse of the 10-, 15-, or 20-year first phase holding period? (Use Schedule C, Form 4720, to determine
if the foundation had excess business holdings in 2023.) .....................
3b
 
 
4a
Did the foundation invest during the year any amount in a manner that would jeopardize its charitable purposes?
4a
 
No
b
Did the foundation make any investment in a prior year (but after December 31, 1969) that could jeopardize its
charitable purpose that had not been removed from jeopardy before the first day of the tax year beginning in 2023? ..
4b
 
No
Form 990-PF (2023)
Form 990-PF (2023)
Page 6
Part VI-B
Statements Regarding Activities for Which Form 4720 May Be Required (continued)
5a
During the year did the foundation pay or incur any amount to:
Yes
No
(1) Carry on propaganda, or otherwise attempt to influence legislation (section 4945(e))? ..........
5a(1)
 
No
(2) Influence the outcome of any specific public election (see section 4955); or to carry
on, directly or indirectly, any voter registration drive? ....................
5a(2)
 
No
(3) Provide a grant to an individual for travel, study, or other similar purposes? .............
5a(3)
 
No
(4) Provide a grant to an organization other than a charitable, etc., organization described
in section 4945(d)(4)(A)? See instructions ........................
5a(4)
 
No
(5) Provide for any purpose other than religious, charitable, scientific, literary, or
educational purposes, or for the prevention of cruelty to children or animals? .............
5a(5)
 
No
b
If any answer is "Yes" to 5a(1)–(5), did any of the transactions fail to qualify under the exceptions described in
Regulations section 53.4945 or in a current notice regarding disaster assistance? See instructions ........
5b
 
 
c
Organizations relying on a current notice regarding disaster assistance check .........right arrow
d
If the answer is "Yes" to question 5a(4), does the foundation claim exemption from the
tax because it maintained expenditure responsibility for the grant? .................
5d
 
 
If "Yes," attach the statement required by Regulations section 53.4945–5(d).
6a
Did the foundation, during the year, receive any funds, directly or indirectly, to pay premiums on
a personal benefit contract? .............................
6a
 
No
b
Did the foundation, during the year, pay premiums, directly or indirectly, on a personal benefit contract? ....
6b
 
No
If "Yes" to 6b, file Form 8870.
7a
At any time during the tax year, was the foundation a party to a prohibited tax shelter transaction?
7a
 
No
b
If "Yes", did the foundation receive any proceeds or have any net income attributable to the transaction? .....
7b
 
 
8
Is the foundation subject to the section 4960 tax on payment(s) of more than $1,000,000 in remuneration or
excess parachute payment during the year? .........................
8
 
No
Part VII
Information About Officers, Directors, Trustees, Foundation Managers, Highly Paid Employees,
and Contractors
1 List all officers, directors, trustees, foundation managers and their compensation. See instructions
(a) Name and address (b) Title, and average
hours per week
devoted to position
(c) Compensation
(If not paid, enter
-0-)
(d) Contributions to employee benefit plans and deferred compensation (e) Expense account,
other allowances
JOHN A LARSEN TREASURER
2
0    
2015 SUMMIT AVENUE
ST PAUL,MN55105
KAREN R LARSEN DIRECTOR
3
0    
2015 SUMMIT AVE
ST PAUL,MN55105
KRISTEN L ROSE DIRECTOR
1
0    
1825 STANFORD AVENUE
ST PAUL,MN55105
JOHN E LARSEN PRESIDENT
5
0    
2002 W LAKE OF THE ISLE PARKWAY
MINNEAPOLIS,MN55405
2 Compensation of five highest-paid employees (other than those included on line 1—see instructions). If none, enter “NONE."
(a) Name and address of each employee paid more than $50,000 (b) Title, and average
hours per week
devoted to position
(c) Compensation (d) Contributions to
employee benefit
plans and deferred
compensation
(e) Expense account,
other allowances
NONE
Total number of other employees paid over $50,000...................right arrow 0
Form 990-PF (2023)
Form 990-PF (2023)
Page 7
Part VII
Information About Officers, Directors, Trustees, Foundation Managers, Highly Paid Employees,
and Contractors (continued)
3 Five highest-paid independent contractors for professional services (see instructions). If none, enter "NONE".
(a) Name and address of each person paid more than $50,000 (b) Type of service (c) Compensation
US BANK INVESTMENT MGMT 54,689
PO BOX 0634
MILWAUKEE,WI53201
Total number of others receiving over $50,000 for professional services.............right arrow0
Part VIII-A
Summary of Direct Charitable Activities
List the foundation’s four largest direct charitable activities during the tax year. Include relevant statistical information such as the number of organizations and other beneficiaries served, conferences convened, research papers produced, etc. Expenses
1  
2  
3  
4  
Part VIII-B
Summary of Program-Related Investments (see instructions)
Describe the two largest program-related investments made by the foundation during the tax year on lines 1 and 2. Amount
1  
2  
All other program-related investments. See instructions.
3  
Total. Add lines 1 through 3.........................right arrow  
Form 990-PF (2023)
Form 990-PF (2023)
Page 8
Part IX
Minimum Investment Return (All domestic foundations must complete this part. Foreign foundations, see instructions.)
1
Fair market value of assets not used (or held for use) directly in carrying out charitable, etc.,
purposes:
a
Average monthly fair market value of securities...................
1a
7,032,374
b
Average of monthly cash balances.......................
1b
300,889
c
Fair market value of all other assets (see instructions)................
1c
0
d
Total (add lines 1a, b, and c).........................
1d
7,333,263
e
Reduction claimed for blockage or other factors reported on lines 1a and
1c (attach detailed explanation) .............
1e
0
2
Acquisition indebtedness applicable to line 1 assets..................
2
0
3
Subtract line 2 from line 1d.........................
3
7,333,263
4
Cash deemed held for charitable activities. Enter 1.5% (0.015) of line 3 (for greater amount, see
instructions) .............................
4
109,999
5
Net value of noncharitable-use assets. Subtract line 4 from line 3. ............
5
7,223,264
6
Minimum investment return. Enter 5% (0.05) of line 5................
6
361,163
Part X
Distributable Amount (see instructions) (Section 4942(j)(3) and (j)(5) private operating foundations and certain foreign organizations check here right arrow and do not complete this part.)
1
Minimum investment return from Part IX, line 6..................
1
361,163
2a
Tax on investment income for 2022 from Part V, line 5.......
2a
3,019
b
Income tax for 2022. (This does not include the tax from Part V.) ...
2b
 
c
Add lines 2a and 2b............................
2c
3,019
3
Distributable amount before adjustments. Subtract line 2c from line 1............
3
358,144
4
Recoveries of amounts treated as qualifying distributions................
4
6,000
5
Add lines 3 and 4............................
5
364,144
6
Deduction from distributable amount (see instructions).................
6
0
7
Distributable amount as adjusted. Subtract line 6 from line 5. Enter here and on Part XII, line 1 ...
7
364,144
Part XI
Qualifying Distributions (see instructions)
1
Amounts paid (including administrative expenses) to accomplish charitable, etc., purposes:
a
Expenses, contributions, gifts, etc.—total from Part I, column (d), line 26 ..........
1a
387,994
b
Program-related investments—total from Part VIII-B..................
1b
0
2
Amounts paid to acquire assets used (or held for use) directly in carrying out charitable, etc.,
purposes...............................
2
0
3
Amounts set aside for specific charitable projects that satisfy the:
a
Suitability test (prior IRS approval required)....................
3a
0
b
Cash distribution test (attach the required schedule) .................
3b
0
4
Qualifying distributions. Add lines 1a through 3b. Enter here and on Part XII, line 4. .......
4
387,994
Form 990-PF (2023)
Form 990-PF (2023)
Page 9
Part XII
Undistributed Income (see instructions)
(a)
Corpus
(b)
Years prior to 2022
(c)
2022
(d)
2023
1 Distributable amount for 2023 from Part X, line 7 364,144
2 Undistributed income, if any, as of the end of 2022:
a Enter amount for 2022 only....... 0
b Total for prior years:20 , 20, 20 0
3 Excess distributions carryover, if any, to 2022:
a From 2018...... 0
b From 2019...... 13,939
c From 2020...... 0
d From 2021...... 141,134
e From 2022...... 37,445
f Total of lines 3a through e ........ 192,518
4Qualifying distributions for 2023 from Part
XI, line 4: right arrow$ 387,994
a Applied to 2022, but not more than line 2a 0
b Applied to undistributed income of prior years
(Election required—see instructions).....
0
c Treated as distributions out of corpus (Election
required—see instructions)........
0
d Applied to 2023 distributable amount..... 364,144
e Remaining amount distributed out of corpus 23,850
5 Excess distributions carryover applied to 2023. 0 0
(If an amount appears in column (d), the
same amount must be shown in column (a).)
6Enter the net total of each column as
indicated below:
a Corpus. Add lines 3f, 4c, and 4e. Subtract line 5 216,368
b Prior years’ undistributed income. Subtract
line 4b from line 2b ..........
0
c Enter the amount of prior years’ undistributed
income for which a notice of deficiency has
been issued, or on which the section 4942(a)
tax has been previously assessed......
0
d Subtract line 6c from line 6b. Taxable amount
—see instructions ...........
0
e Undistributed income for 2022. Subtract line
4a from line 2a. Taxable amount—see
instructions .............
0
f Undistributed income for 2023. Subtract
lines 4d and 5 from line 1. This amount must
be distributed in 2024 ..........
0
7 Amounts treated as distributions out of
corpus to satisfy requirements imposed by
section 170(b)(1)(F) or 4942(g)(3) (Election may
be required - see instructions) .......
0
8 Excess distributions carryover from 2018 not
applied on line 5 or line 7 (see instructions) ...
0
9 Excess distributions carryover to 2024.
Subtract lines 7 and 8 from line 6a ......
216,368
10 Analysis of line 9:
a Excess from 2019.... 13,939
b Excess from 2020.... 0
c Excess from 2021.... 141,134
d Excess from 2022.... 37,445
e Excess from 2023.... 23,850
Form 990-PF (2023)
Form 990-PF (2023)
Page 10
Part XIII
Private Operating Foundations (see instructions and Part VI-A, question 9)
1a If the foundation has received a ruling or determination letter that it is a private operating
foundation, and the ruling is effective for 2023, enter the date of the ruling ...... right arrow
 
b Check box to indicate whether the organization is a private operating foundation described in section or
2a Enter the lesser of the adjusted net
income from Part I or the minimum
investment return from Part IX for each
year listed ..........
Tax year Prior 3 years (e) Total
(a) 2023 (b) 2022 (c) 2021 (d) 2020
         
b 85% (0.85) of line 2a .........          
c Qualifying distributions from Part XI,
line 4 for each year listed .....
         
d Amounts included in line 2c not used directly
for active conduct of exempt activities ..........
         
e Qualifying distributions made directly
for active conduct of exempt activities.
Subtract line 2d from line 2c ....
         
3 Complete 3a, b, or c for the
alternative test relied upon:
a “Assets" alternative test—enter:
(1) Value of all assets ......          
(2) Value of assets qualifying
under section 4942(j)(3)(B)(i)
         
b “Endowment" alternative test— enter 2/3
of minimum investment return shown in
Part IX, line 6 for each year listed ..
         
c “Support" alternative test—enter:
(1) Total support other than gross
investment income (interest,
dividends, rents, payments
on securities loans (section
512(a)(5)), or royalties) ....
         
(2) Support from general public
and 5 or more exempt
organizations as provided in
section 4942(j)(3)(B)(iii)....
         
(3) Largest amount of support
from an exempt organization
         
(4) Gross investment income          
Part XIV
Supplementary Information (Complete this part only if the foundation had $5,000 or more in
assets at any time during the year—see instructions.)
1Information Regarding Foundation Managers:
aList any managers of the foundation who have contributed more than 2% of the total contributions received by the foundation
before the close of any tax year (but only if they have contributed more than $5,000). (See section 507(d)(2).)
NONE
bList any managers of the foundation who own 10% or more of the stock of a corporation (or an equally large portion of the
ownership of a partnership or other entity) of which the foundation has a 10% or greater interest.
NONE
2Information Regarding Contribution, Grant, Gift, Loan, Scholarship, etc., Programs:
Check here right arrow
aThe name, address, and telephone number or email address of the person to whom applications should be addressed:
bThe form in which applications should be submitted and information and materials they should include:
cAny submission deadlines:
dAny restrictions or limitations on awards, such as by geographical areas, charitable fields, kinds of institutions, or other
factors:
Form 990-PF (2023)
Form 990-PF (2023)
Page 11
Part XIV
Supplementary Information (continued)
3 Grants and Contributions Paid During the Year or Approved for Future Payment
Recipient If recipient is an individual,
show any relationship to
any foundation manager
or substantial contributor
Foundation
status of
recipient
Purpose of grant or
contribution
Amount
Name and address (home or business)
aPaid during the year

FRASER

240 W 64TH ST
MINNEAPOLIS,MN55423
NONE PC GENERAL OPERATING 10,000

SPCO ANNUAL FUND

408 SAINT PETER STREET STE 300
SAINT PAUL,MN55102
NONE PC GENERAL OPERATING 10,000

FRIENDS OF THE SPCO

408 ST PETER STREET STE 300
ST PAUL,MN55102
NONE PC GENERAL OPERATION 12,000

RESTORATIVE JUSTICE COMMUNITY ACTION

401 GROVELAND AVE NO 50
MINNEAPOLIS,MN554033219
NONE PC GENERAL OPERATING 7,500

CONSERVATION MINNESOTA

1101 W RIVER PKWY STE 250
MINNEAPOLIS,MN554154853
NONE PC GENERAL OPERATING 90,000

WEARE

PO BOX 1086
BRAINERD,MN56401
NONE PC GENERAL OPERATING 4,000

NATURE CONSERVANCY

4245 FAIRFAX DR STE 100
ARLINGTON,VA222031637
NONE PC GENERAL OPERATING 5,000

ST PAUL ACADEMY SUMMIT SCHOOL

1712 RANDOLPH AVE
ST PAUL,MN55105
NONE PC GENERAL OPERATING 5,000

ALL SQUARE

4047 MINNEHAHA AVE
MINNEAPOLIS,MN554063305
NONE PC GENERAL OPERATING 3,000

OUTFRONT MINNESOTA

2446 UNIVERSITY AVE W SUITE 112
ST PAUL,MN551140000
NONE PC GENERAL OPERATING 25,000

PEASE COMMUNITY FOUNDATION

601 13TH AVE SE
MINNEAPOLIS,MN554141437
NONE PC GENERAL OPERATING 2,500

WHITEFISH AREA PROPERTY OWNERS ASSN

PO BOX 342
CROSSLAKE,MN564420342
NONE PC GENERAL OPERATING 4,000

MN CENTER FOR ENVIRONMENTAL ADVOCACY

26 EXCHANGE STREET SUITE 206
SAINT PAUL,MN55101
NONE PC GENERAL OPERATING 15,000

GIVEMN

101 FIFTH STREET EAST STE 2400
ST PAUL,MN55101
NONE PC GENERAL OPERATING 10,000

UJAMAA PLACE

1821 UNIVERSITY AVE W STE N257
SAINT PAUL,MN551042870
NONE PC GENERAL OPERATING 3,000

NATIONAL WILDLIFE TURKEY FEDERATION

13075 LINNET ST NW
COON RAPIDS,MN55448
NONE PC GENERAL OPERATING 10,000

AVENUES FOR HOMELESS YOUTH

1708 OAK PARK AVENUE N
MINNEAPOLIS,MN55411
NONE PC GENERAL OPERATING 12,500

PLANNED PARENTHOOD N CENTRAL STATES

671 VANDALIA ST STE 323
ST PAUL,MN55114
NONE PC GENERAL OPERATING 18,500

PARK SQUARE THEATER

408 ST PETER ST STE 110
ST PAUL,MN55102
NONE PC GENERAL OPERATING 30,000

ENVIRONMENTAL INITIATIVE

807 BROADWAY ST NE STE 230
MINNEAPOLIS,MN554132490
NONE PC GENERAL OPERATING 2,500

FRESH ENERGY

408 ST PETER STREET STE 220
ST PAUL,MN55102
NONE PC GENERAL OPERATING 23,500

LAKES AREA RESTORATIVE JUSTICE

424 NW 3RD ST
BRAINERD,MN56401
NONE PC GENERAL OPERATING 35,000

SIERRA CLUB FOUNDATION

2300 MYRTLE AVE SUITE 260
ST PAUL,MN55114
NONE PC GENERAL OPERATING 10,000

NAMI MN

1919 UNIVERSITY AVE W 400
St Paul,MN55104
NONE PC GENERAL OPERATING 3,000

ADVOCATES FOR REPRODUCTIVE EDUCATION

PO BOX 1086
BRAINERD,MN56401
NONE PC GENERAL OPERATING 15,000

JUST THE PILL

2038 FORD PKWY 444
ST PAUL,MN55116
NONE PC GENERAL OPERATING 5,000

AMAZE WORKS INC

475 CLEVELAND AVE N STE 322
ST PAUL,MN55104
NONE PC GENERAL OPERATING 8,000
Total .................................right arrow 3a 379,000
bApproved for future payment
Total ................................. right arrow 3b  
Form 990-PF (2023)
Form 990-PF (2023)
Page 12
Part XV-A
Analysis of Income-Producing Activities
Enter gross amounts unless otherwise indicated. Unrelated business income Excluded by section 512, 513, or 514 (e)
Related or exempt
function income
(See instructions.)
1Program service revenue: (a)
Business code
(b)
Amount
(c)
Exclusion code
(d)
Amount
a
b
c
d
e
f
gFees and contracts from government agencies          
2 Membership dues and assessments ....          
3 Interest on savings and temporary cash
investments ...........
         
4 Dividends and interest from securities ....     14 145,368  
5 Net rental income or (loss) from real estate:
aDebt-financed property......          
bNot debt-financed property.....          
6 Net rental income or (loss) from personal property          
7 Other investment income .....          
8 Gain or (loss) from sales of assets other than
inventory ............
    18 121,215  
9 Net income or (loss) from special events:          
10 Gross profit or (loss) from sales of inventory          
11 Other revenue:
aOTHER INCOME
    1 297  
b
c
d
e
12 Subtotal. Add columns (b), (d), and (e) ..   266,880  
13Total. Add line 12, columns (b), (d), and (e)..................
13
266,880
(See worksheet in line 13 instructions to verify calculations.)
Part XV-B
Relationship of Activities to the Accomplishment of Exempt Purposes
Line No.
DownArrow
Explain below how each activity for which income is reported in column (e) of Part XV-A contributed importantly to
the accomplishment of the foundation’s exempt purposes (other than by providing funds for such purposes). (See
instructions.)
Form 990-PF (2023)
Form 990-PF (2023)
Page 13
Part XVI
Information Regarding Transfers To and Transactions and Relationships With Noncharitable Exempt Organizations
1
Did the organization directly or indirectly engage in any of the following with any other organization described in section 501(c) (other than section 501(c)(3) organizations) or in section 527, relating to political organizations?
Yes
No
a
Transfers from the reporting foundation to a noncharitable exempt organization of:
(1) Cash...................................
1a(1)
 
No
(2) Other assets.................................
1a(2)
 
No
b
Other transactions:
(1) Sales of assets to a noncharitable exempt organization....................
1b(1)
 
No
(2) Purchases of assets from a noncharitable exempt organization..................
1b(2)
 
No
(3) Rental of facilities, equipment, or other assets.......................
1b(3)
 
No
(4) Reimbursement arrangements...........................
1b(4)
 
No
(5) Loans or loan guarantees.............................
1b(5)
 
No
(6) Performance of services or membership or fundraising solicitations................
1b(6)
 
No
c
Sharing of facilities, equipment, mailing lists, other assets, or paid employees..............
1c
 
No
d
If the answer to any of the above is "Yes," complete the following schedule. Column (b) should always show the fair market value
of the goods, other assets, or services given by the reporting foundation. If the foundation received less than fair market value
in any transaction or sharing arrangement, show in column (d) the value of the goods, other assets, or services received.
(a) Line No. (b) Amount involved (c) Name of noncharitable exempt organization (d) Description of transfers, transactions, and sharing arrangements
2a
Is the foundation directly or indirectly affiliated with, or related to, one or more tax-exempt organizations
described in section 501(c) (other than section 501(c)(3)) or in section 527? ...........
b
If "Yes," complete the following schedule.

(a) Name of organization (b) Type of organization (c) Description of relationship
Sign Here
Under penalties of perjury, I declare that I have examined this return, including accompanying schedules and statements, and to the best of my knowledge and belief, it is true, correct, and complete. Declaration of preparer (other than taxpayer) is based on all information of which preparer has any knowledge.
right arrow right arrow
May the IRS discuss this return
with the preparer shown below?
See instructions.
Signature of officer or trustee Date Title
Paid Preparer Use Only Print/Type preparer's name Preparer's Signature Date Check if self-
employed right arrow
PTIN
Firm's name SmallBullet
Firm's EIN SmallBullet
Firm's address SmallBullet


Phone no.
Form 990-PF (2023)
Additional Data


Software ID:  
Software Version:  


Form 990PF - Special Condition Description:
Special Condition Description

TY 2023 AccountingFeesSchedule
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Category Amount Net Investment Income Adjusted Net Income Disbursements for Charitable Purposes
TAX PREPARATION FEE (NON-ALLOC 1,500     1,500

TY 2023 InvestmentsCorpBondsSchedule
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Name of Bond End of Year Book Value End of Year Fair Market Value
949746SH5 WELLS FARGO COMPANY 71,734 71,203
89236TDR3 TOYOTA MOTOR MTN 75,180 72,284
92826CAD4 VISA INC 75,149 73,175
037833AS9 APPLE INC 75,221 74,479
14912L5Q0 CATERPILLAR FIN MTN    
78013XW20 ROYAL BANK MTN    
89115A2A9 TORONTO DOMINION MTN 198,232 196,774
855244AV1 STARBUCKS CORP 183,632 185,180
291011BR4 EMERSON ELEC CO 84,566 85,451
458140BZ2 INTEL CORP 97,191 98,412
501044DP3 THE KROGER CO 84,104 85,579
63743HFG2 NATIONAL RURAL MTN 50,558 50,570
68389XBN4 ORACLE CORP 182,176 189,874
91324PEU2 UNITEDHEALTH GROUP 99,511 99,837
023135CH7 AMAZON COM 94,766 95,257
20030NCT6 COMCAST CORP 98,881 98,607
254687FQ4 DISNEY WALT CO SR 96,770 97,075

TY 2023 InvestmentsCorpStockSchedule
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Name of Stock End of Year Book Value End of Year Fair Market Value
231021106 CUMMINS INC COM 10,472 21,322
860630102 STIFEL FINL CORP 11,667 26,969
361448103 G A T X CORP 8,759 21,159
833034101 SNAP ON INC 8,325 29,462
81211K100 SEALED AIR CORP 15,267 18,370
00507V109 ACTIVISION BLIZZARD    
548661107 LOWES CO INC 27,062 121,735
194162103 COLGATE PALMOLIVE CO 31,705 37,783
743315103 PROGRESSIVE CORP 37,446 68,013
980745103 WOODWARD INC 8,724 25,320
50540R409 LABORATORY CRP OF AM 16,343 26,593
49338L103 KEYSIGHT TECHNOLOGIE 6,934 33,568
00971T101 AKAMAI TECHNOLOGIES 23,884 37,280
052769106 AUTODESK INC 39,266 38,957
H1467J104 CHUBB LTD 27,226 60,568
46625H100 J P MORGAN CHASE CO 26,283 80,627
G1151C101 ACCENTURE PLC CL A 23,695 107,028
31620M106 FIDELITY NATIONAL IN    
493267108 KEYCORP 18,726 22,392
090572207 BIO RAD LABS INC CL 14,075 20,988
871607107 SYNOPSYS INC 2,995 43,767
759351604 REINSURANCE GROUP AM 15,125 31,709
126408103 CSX CORP 9,349 28,395
369550108 GENERAL DYNAMICS COR 9,842 27,525
G7496G103 RENAISSANCE RE HOLDI 15,109 25,284
23331A109 D R HORTON INC 6,052 38,907
872540109 TJX COMPANIES INC 5,336 22,421
92939U106 WEC ENERGY GROUP INC 14,185 21,295
65339F101 NEXTERA ENERGY INC 17,319 57,824
12504L109 CBRE GROUP INC 10,450 38,819
461202103 INTUIT INC 28,307 57,503
37940X102 GLOBAL PAYMENTS INC 7,484 25,527
G5960L103 MEDTRONIC PLC    
037833100 APPLE INC 6,405 180,208
03662Q105 A N S Y S INC 8,273 37,740
810186106 THE SCOTTS MIRACLE G 28,488 22,376
760759100 REPUBLIC SVCS INC 8,857 46,505
695156109 PACKAGING CORP AMERI 8,446 21,015
254687106 DISNEY WALT CO    
91324P102 UNITED HEALTH GROUP 24,641 128,459
718546104 PHILLIPS 66 36,151 65,372
97650W108 WINTRUST FINANCIAL C 3,730 6,493
754730109 RAYMOND JAMES FINL I 5,277 31,443
17275R102 CISCO SYSTEMS INC 44,791 65,272
00206R102 ATT INC    
594918104 MICROSOFT CORP 48,087 296,320
713448108 PEPSICO INC 34,897 62,161
277432100 EASTMAN CHEM CO 19,238 22,814
24906P109 DENTSPLY SIRONA INC 24,337 19,859
260003108 DOVER CORP 15,548 27,840
574599106 MASCO CORP 15,776 39,049
45866F104 INTERCONTINENTAL EXC 8,148 33,007
438516106 HONEYWELL INTERNATIO 17,927 49,282
02079K107 ALPHABET INC CL C 21,644 50,735
00846U101 AGILENT TECHNOLOGIES 8,178 30,726
101121101 BOSTON PPTYS INC 24,711 19,507
237194105 DARDEN RESTAURANTS I 11,178 35,982
03073E105 AMERISOURCEBERGEN CO 6,619 27,932
28176E108 EDWARDS LIFESCIENCES 55,541 97,066
012653101 ALBEMARLE CORP 11,630 17,338
00912X302 AIR LEASE CORP 25,378 27,219
29977A105 EVERCORE INC 4,641 6,500
042735100 ARROW ELECTRONICS IN 15,474 23,839
858912108 STERICYCLE INC COMMO 17,545 15,760
87166B102 SYNEOS HEALTH INC    
G5494J103 LINDE PLC    
12572Q105 CME GROUP INC    
718172109 PHILIP MORRIS INTL    
09215C105 BLACK KNIGHT INC    
00191U102 ASGN INC    
441593100 HOULIHAN LOKEY INC 13,398 30,937
882508104 TEXAS INSTRUMENTS IN 42,117 71,764
038222105 APPLIED MATERIALS IN 5,940 24,311
G8060N102 SENSATA TECHNOLOGIES 28,436 22,279
025816109 AMERICAN EXPRESS CO 48,061 73,250
03064D108 AMERICOLD REALTY TRU 23,951 25,064
83088M102 SKYWORKS SOLUTIONS I 22,604 25,632
693475105 P N C FINANCIAL SERV    
57667L107 MATCH GROUP INC NEW 57,808 21,718
57776J100 MAXLINEAR INC CLASS    
197236102 COLUMBIA BKG SYS INC 7,022 6,617
739276103 POWER INTEGRATIONS I 1,582 1,642
16115Q308 CHART INDUSTRIES INC 4,139 5,181
22160K105 COSTCO WHSL CORP 30,087 52,806
172908105 CINTAS CORP 18,432 39,776
35138V102 FOX FACTORY HOLDING    
05464T104 AXSOME THERAPEUTICS 2,527 3,422
199908104 COMFORT SYS USA INC 566 3,085
207410101 CONMED CORP 2,782 2,957
00724F101 ADOBE SYS INC 32,688 44,148
950755108 WERNER ENTERPRISES I    
74758T303 QUALYS INC 2,411 3,533
82509L107 SHOPIFY INC A    
46120E602 INTUITIVE SURGICAL I 28,861 49,255
59064R109 MESA LABS INC    
229050307 CRYPORT INC    
252131107 DEXCOM INC    
057665200 BALCHEM CORP 2,272 3,421
023135106 AMAZON.COM INC 48,982 51,508
19247A100 COHEN STEERS INC 5,578 6,740
98978V103 ZOETIS INC 24,517 34,934
78410G104 SBA COMMUNICATIONS C 71,804 71,541
81762P102 SERVICENOW INC 38,655 55,813
11373M107 BROOKLINE BANCORP IN    
09239B109 BLACKLINE INC    
05550J101 BJS WHOLESALE CLUB H    
012348108 ALBANY INTL CORP CL 3,121 4,223
93148P102 WALKER & DUNLOP INC 3,812 5,106
34417P100 FOCUS FINANCIAL PART    
88146M101 TERRENO REALTY CORP 5,676 6,768
871829107 SYSCO CORP 16,547 21,866
N6596X109 NXP SEMICONDUCTORS N 13,137 25,494
776696106 ROPER INDS INC    
550021109 LULULEMON ATHLETICA 28,384 44,994
00287Y109 ABBVIE INC    
826919102 SILICON LABORATORIES 1,430 1,720
115637209 BROWN FORMAN CORP CL    
453836108 INDEPENDENT BK CORP 5,124 5,857
883556102 THERMO FISHER SCIENT 26,789 36,625
87157D109 SYNAPTICS INC    
57636Q104 MASTERCARD INC 31,700 45,210
502431109 L3HARRIS TECHNOLOGIE    
518439104 LAUDER ESTEE COS INC    
922280102 VARONIS SYSTEMS INC 3,389 4,256
92839U206 VISTEON CORP 2,194 2,623
808513105 SCHWAB CHARLES CORP 43,319 61,782
971378104 WILLSCOT MOBIL MINI    
75524B104 RBC BEARINGS INC    
127097103 COTERRA ENERGY INC 7,114 25,214
674215207 CHORD ENERGY CORPORA 2,004 3,823
848574109 SPIRIT AEROSYSTEMS H 28,190 30,541
05478C105 AZEK CO INC CL A 1,527 2,104
16679L109 CHEWY INC CLASS A 46,381 13,729
527064109 LESLIES INC    
55405Y100 MA COM TECH SOLUTION 1,232 1,859
98139A105 WORKIVA INC 2,272 2,944
11133T103 BROADRIDGE FINANCIAL 23,654 26,748
353514102 FRANKLIN ELEC INC 1,899 2,126
404030108 H E EQUIPMENT SERVI    
43283X105 HILTON GRAND VACATIO 2,366 2,371
127203107 CACTUS INC A 1,907 2,315
27627N105 EASTERN BANKSHARES I    
043436104 ASBURY AUTOMOTIVE GR 3,501 4,049
45167R104 IDEX CORP 14,487 16,283
393222104 GREEN PLAINS INC.    
44267D107 HOWARD HUGHES CORP/T    
23282W605 CYTOKINETICS INC 833 835
86614U100 SUMMIT MATERIALS INC 3,015 5,038
880779103 TEREX CORP    
922475108 VEEVA SYSTEMS INC-CL 30,482 22,717
553368101 MP MATLS CORP    
G4388N106 HELEN OF TROY LTD 3,508 4,108
13100M509 CALIX NETWORKS INC    
86333M108 STRIDE INC    
127190304 CACI INTERNATIONAL I 2,723 3,239
423452101 HELMERICH PAYNE INC 21,781 17,458
205768302 COMSTOCK RESOURCES I    
28618M106 ELEMENT SOLUTIONS IN 3,670 4,397
55024U109 LUMENTUM HOLDINGS IN 30,557 19,186
00973Y108 AKERO THERAPEUTICS I    
44925C103 ICF INTERNATIONAL IN 3,715 4,693
G72800108 PROTHENA CORP PLC    
82982T106 SITIME CORP    
016255101 ALIGN TECH INC COM 30,543 31,784
49714P108 KINSALE CAPITAL GROU    
G037AX101 AMBARELLA INC    
92790C104 VIRIDIAN THERAPEUTIC    
92332V107 VENTYX BIOSCIENCES I    
580589109 MCGRATH RENTCORP    
184496107 CLEAN HBRS INC 1,657 2,443
761330109 REVANCE THERAPEUTICS    
05465P101 AXONICS MODULATION T    
67066G104 NVIDIA CORP 23,580 54,474
48576A100 KARUNA THERAPEUTICS    
049468101 ATLASSIAN CORPORATIO 26,491 37,344
516544103 LANTHEUS HOLDINGS IN    
27032D304 EARTHSTONE ENERGY IN    
398433102 GRIFFON CORP    
844895102 SOUTHWEST GAS HOLDIN 7,456 6,018
92686J106 VIKING THERAPEUTICS    
74349U108 PROMETHEUS BIOSCIENC    
05605H100 BWX TECHNOLOGIES INC 3,325 4,834
775133101 ROGERS CORP 2,233 2,377
76029N106 REPLIMUNE GROUP INC    
646025106 NEW JERSEY RESOURCES    
67000B104 NOVANTA INC 1,641 2,358
68404L201 OPTION CARE HEALTH I 2,817 3,066
87901J105 TEGNA INC 2,739 2,173
09627Y109 BLUEPRINT MEDICINES    
227046109 CROCS INC    
03237H101 AMYLYX PHARMACEUTICA    
G3682E192 FRONTLINE LTD ORDINA    
53814L108 LIVENT CORP    
42226A107 HEALTHEQUITY INC    
82489T104 SHOCKWAVE MEDICAL IN    
925050106 VERONA PHARMA PLC A 2,675 4,374
428291108 HEXCEL CORP NEW COM 15,983 20,871
148806102 CATALENT INC 37,615 21,971
78409V104 S P GLOBAL INC 38,525 44,493
30226D106 EXTREME NETWORKS INC 1,075 988
29362U104 ENTEGRIS INC 31,810 39,780
165303108 CHESAPEAKE UTILITIES    
04280A100 ARROWHEAD PHARMACEUT 1,379 1,040
Y7542C130 SCORPIO TANKERS INC 4,657 5,168
368736104 GENERAC HOLDINGS INC 23,821 27,011
029899101 AMERICAN STATES WATE    
736508847 PORTLAND GENERAL ELE 3,392 3,077
000360206 AAON INC    
68213N109 OMNICELL INC COM    
296315104 E S C O TECHNOLOGIES 2,786 3,043
31188V100 FASTLY INC CLASS A 1,608 1,566
346232101 FORESTAR GROUP INC 3,167 4,068
358054104 FRESHWORKS INC CLASS 2,752 3,195
498894104 KNIFE RIV HLDG CO 4,089 5,493
513847103 LANCASTER COLONY COR 3,743 3,661
52661A108 RADA ELECTR INDS LTD 5,652 6,413
558868105 MADRIGAL PHARMACEUTI 1,063 1,157
59001A102 MERITAGE HOMES CORPO 3,104 4,007
59100U108 PATHWARD FINANCIAL I 4,770 4,764
626717102 MURPHY OIL CORP 14,927 15,059
65290E101 NEXTRACKER INC CLASS 3,565 4,029
683344105 ONTO INNOVATION INC 1,684 2,294
691497309 OXFORD INDS INC 1,471 1,600
69404D108 PACIFIC BIOSCIENCES 2,623 3,139
71424F105 PERMIAN RESOURCES CO 3,628 4,230
74366E102 PROTAGONIST THERAPEU 899 1,009
750917106 RAMBUS INC 1,822 2,321
77313F106 ROCKET PHARMACEUTICA 547 779
78440X887 SL GREEN REALTY CORP 3,819 4,743
78463M107 SPS COMMERCE INC 3,705 4,652
80874P109 SCIENTIFIC GAMES COR 4,660 4,598
825704109 SI BONE INC 1,824 1,532
82900L102 SIMPLY GOOD FOODS CO 5,092 5,504
829073105 SIMPSON MFG CO INC 1,874 3,168
830940102 SKYWARD SPECIALTY IN 4,238 5,048
85254J102 STAG INDUSTRIAL INC 3,560 4,122
86800U104 SUPER MICRO COMPUTER 2,046 2,558
89377M109 TRANSMEDICS GROUP IN 2,066 2,605
896945201 TRIPADVISOR INC COM 2,510 2,476
90353T100 UBER TECHNOLOGIES IN 31,857 43,653
90384S303 ULTRA SALON COSMETIC 25,602 25,969
92243G108 VAXCYTE INC COM 2,998 3,894
92338C103 VERALTO CORP COM SHS 21,980 24,349
G01767105 ALKERMES PLC 1,036 1,054
G25457105 CREDO TECHNOLOGY GRO 2,555 2,862
G54950103 LINDE PLC SHS 40,539 99,803
G8068L108 SHARKNINJA INC 4,297 5,015
007973100 ADVANCED ENERGY INDS 2,568 2,505
01741R102 ALLEGHENY TECHNOLOGI 4,629 5,138
03209R103 AMPHASTAR PHARMACEUT 2,382 2,721
03937C105 ARCBEST CORP 2,510 2,885
047649108 ATKORE INTERNATIONAL 3,200 3,520
05969A105 BANCORP INC DEL 4,609 5,051
07831C103 BELLRING DISTR LLC C 1,083 2,716
099406100 BOOT BARN HOLDINGS I 1,531 1,458
10806X102 BRIDGEBIO PHARMA INC 1,804 3,270
14888U101 CATALYST PHARMACEUTI 3,529 3,782
15872M104 CHAMPIONX CORPORATIO 17,278 16,007
21044C107 CONSTRUCTION PARTNER 2,833 3,046
22160N109 COSTAR GRP INC COM 29,072 36,529
23257D103 CYMABAY THERAPEUTICS 2,031 4,157
25271C201 DIAMOND OFFSHORE DRI 3,666 3,302
25402D102 DIGITALOCEAN HLDGS I 1,303 1,724
26856L103 E L F BEAUTY INC 2,359 3,320

TY 2023 InvestmentsOtherSchedule2
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Category/ Item Listed at Cost or FMV Book Value End of Year Fair Market Value
994120ZM8 PROPEL NONPROFITS 1. AT COST 100,000 100,000
994120ZN6 MCCD 1.0% 06/01/2026 AT COST 100,000 100,000
9AMCP0DT5 COLLATERAL REQUIRED      
922908769 VANGUARD TOTAL STOCK AT COST 678,462 1,067,490
07831C103 BELLRING DISTR LLC C      

TY 2023 OtherAssetsSchedule
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Description Beginning of Year - Book Value End of Year - Book Value End of Year - Fair Market Value
000000000 MISCELLANEOUS ENTRY 835 1,536 1,536


TY 2023 OtherDecreasesSchedule
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Description Amount
PY PENDING SALES 1,223
ROC ADJ ON CY SALES 23


TY 2023 OtherExpensesSchedule
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Description Revenue and Expenses per Books Net Investment Income Adjusted Net Income Disbursements for Charitable Purposes
OTHER MISC EXPENSES 2,000 0   2,000
STATE FILING FEE/TAX 25 0   25
ADR FEES 6 6   0


TY 2023 OtherIncomeSchedule2
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Description Revenue And Expenses Per Books Net Investment Income Adjusted Net Income
OTHER INCOME 297 297  


TY 2023 OtherIncreasesSchedule
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Description Amount
GRANT RECOVERY 6,000
ROUNDING 19


Note: To capture the full content of this document, please select landscape mode (11" x 8.5") when printing.

TY 2023 OtherNotesLoansRcvblLongSch
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465

Borrower's Name Relationship to Insider Original Amount of Loan Balance Due Date of Note Maturity Date Repayment Terms Interest Rate Security Provided by Borrower Purpose of Loan Description of Lender Consideration Consideration FMV
CITY OF LAKES COMMUNITY LAND TRUST   200,000   2016-10 2016-04   4.000 %        
CITY OF LAKES COMMUNITY LAND TRUST   100,000   2016-06 2018-04   3.000 %        
CITY OF LAKES COMMUNITY LAND TRUST   100,000   2016-04 2019-04   4.000 %        

TY 2023 OtherProfessionalFeesSchedule
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Category Amount Net Investment Income Adjusted Net Income Disbursements for Charitable Purposes
OTHER EXPENSE (NON-DEDUCTIBLE 54,689 49,220   5,469


TY 2023 TaxesSchedule
Name:
JOHN LARSEN FOUNDATION MNG AGY (PLG)
EIN:
41-1715465
Category Amount Net Investment Income Adjusted Net Income Disbursements for Charitable Purposes
FOREIGN TAXES 99 99   0